Frequencies for first 10,000 rows of pt variable in reac2009q1 dataset : 'Preferred Term'-level medical | terminology describing the event | Freq. Percent Cum. ----------------------------------------+----------------------------------- ABASIA | 22 0.22 0.22 ABDOMINAL ADHESIONS | 1 0.01 0.23 ABDOMINAL DISCOMFORT | 17 0.17 0.40 ABDOMINAL DISTENSION | 15 0.15 0.55 ABDOMINAL HERNIA | 2 0.02 0.57 ABDOMINAL INFECTION | 1 0.01 0.58 ABDOMINAL INJURY | 1 0.01 0.59 ABDOMINAL OPERATION | 1 0.01 0.60 ABDOMINAL PAIN | 58 0.58 1.18 ABDOMINAL PAIN LOWER | 14 0.14 1.32 ABDOMINAL PAIN UPPER | 33 0.33 1.65 ABDOMINAL TENDERNESS | 1 0.01 1.66 ABNORMAL BEHAVIOUR | 10 0.10 1.76 ABNORMAL DREAMS | 9 0.09 1.85 ABNORMAL FAECES | 2 0.02 1.87 ABNORMAL LOSS OF WEIGHT | 1 0.01 1.88 ABNORMAL WITHDRAWAL BLEEDING | 3 0.03 1.91 ABORTION | 1 0.01 1.92 ABORTION INDUCED | 7 0.07 1.99 ABORTION SPONTANEOUS | 11 0.11 2.10 ABSCESS | 4 0.04 2.14 ABSCESS DRAINAGE | 2 0.02 2.16 ABSCESS JAW | 1 0.01 2.17 ABSCESS LIMB | 1 0.01 2.18 ACCIDENTAL DRUG INTAKE BY CHILD | 1 0.01 2.19 ACCIDENTAL EXPOSURE | 2 0.02 2.21 ACCIDENTAL NEEDLE STICK | 1 0.01 2.22 ACCIDENTAL OVERDOSE | 3 0.03 2.25 ACIDOSIS | 3 0.03 2.28 ACNE | 3 0.03 2.31 ACQUIRED HAEMOPHILIA | 1 0.01 2.32 ACTINIC KERATOSIS | 1 0.01 2.33 ACTIVATED PARTIAL THROMBOPLASTIN TIME.. | 3 0.03 2.36 ACTIVATION SYNDROME | 1 0.01 2.37 ACTIVITIES OF DAILY LIVING IMPAIRED | 9 0.09 2.46 ACUTE CORONARY SYNDROME | 1 0.01 2.47 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS | 1 0.01 2.48 ACUTE GENERALISED EXANTHEMATOUS PUSTU.. | 1 0.01 2.49 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN | 1 0.01 2.50 ACUTE HEPATIC FAILURE | 3 0.03 2.53 ACUTE INTERSTITIAL PNEUMONITIS | 1 0.01 2.54 ACUTE MYELOID LEUKAEMIA | 4 0.04 2.58 ACUTE MYOCARDIAL INFARCTION | 7 0.07 2.65 ACUTE PHASE REACTION | 1 0.01 2.66 ACUTE PSYCHOSIS | 1 0.01 2.67 ACUTE PULMONARY OEDEMA | 5 0.05 2.72 ACUTE RESPIRATORY DISTRESS SYNDROME | 7 0.07 2.79 ACUTE RESPIRATORY FAILURE | 2 0.02 2.81 ADAMS-STOKES SYNDROME | 1 0.01 2.82 ADENOCARCINOMA PANCREAS | 1 0.01 2.83 ADENOVIRAL HAEMORRHAGIC CYSTITIS | 1 0.01 2.84 ADHESION | 1 0.01 2.85 ADRENAL DISORDER | 2 0.02 2.87 ADRENAL HAEMORRHAGE | 1 0.01 2.88 ADRENAL INSUFFICIENCY | 1 0.01 2.89 ADRENAL NEOPLASM | 1 0.01 2.90 ADVERSE DRUG REACTION | 7 0.07 2.97 ADVERSE EVENT | 10 0.10 3.07 ADVERSE REACTION | 1 0.01 3.08 AFFECT LABILITY | 1 0.01 3.09 AFFECTIVE DISORDER | 2 0.02 3.11 AGEUSIA | 3 0.03 3.14 AGGRESSION | 11 0.11 3.25 AGITATION | 17 0.17 3.42 AGONAL RHYTHM | 2 0.02 3.44 AGRANULOCYTOSIS | 5 0.05 3.49 AIDS ENCEPHALOPATHY | 1 0.01 3.50 AKATHISIA | 3 0.03 3.53 ALANINE AMINOTRANSFERASE INCREASED | 28 0.28 3.81 ALCOHOL POISONING | 4 0.04 3.85 ALCOHOL USE | 3 0.03 3.88 ALCOHOLISM | 1 0.01 3.89 ALLERGIC GRANULOMATOUS ANGIITIS | 1 0.01 3.90 ALLERGY TEST POSITIVE | 1 0.01 3.91 ALOPECIA | 21 0.21 4.12 ALTERED STATE OF CONSCIOUSNESS | 9 0.09 4.21 ALTERED VISUAL DEPTH PERCEPTION | 1 0.01 4.22 ALVEOLITIS | 1 0.01 4.23 AMAUROSIS | 1 0.01 4.24 AMENORRHOEA | 12 0.12 4.36 AMNESIA | 20 0.20 4.56 AMNIORRHOEA | 1 0.01 4.57 AMNIOTIC FLUID VOLUME DECREASED | 1 0.01 4.58 AMYLOIDOSIS | 1 0.01 4.59 AMYOTROPHIC LATERAL SCLEROSIS | 1 0.01 4.60 ANAEMIA | 55 0.55 5.15 ANAEMIA HAEMOLYTIC AUTOIMMUNE | 1 0.01 5.16 ANAEMIA POSTOPERATIVE | 1 0.01 5.17 ANAESTHETIC COMPLICATION NEUROLOGICAL | 1 0.01 5.18 ANAL ABSCESS | 1 0.01 5.19 ANAL FISTULA | 3 0.03 5.22 ANAL HAEMORRHAGE | 2 0.02 5.24 ANAL SPHINCTER ATONY | 1 0.01 5.25 ANAPHYLACTIC REACTION | 9 0.09 5.34 ANAPHYLACTIC SHOCK | 9 0.09 5.43 ANEURYSM | 2 0.02 5.45 ANGER | 5 0.05 5.50 ANGINA PECTORIS | 6 0.06 5.56 ANGINA UNSTABLE | 1 0.01 5.57 ANGIOEDEMA | 7 0.07 5.64 ANGIOPLASTY | 2 0.02 5.66 ANGIOTENSIN CONVERTING ENZYME INCREASED | 1 0.01 5.67 ANGLE CLOSURE GLAUCOMA | 1 0.01 5.68 ANHEDONIA | 7 0.07 5.75 ANIMAL SCRATCH | 1 0.01 5.76 ANION GAP DECREASED | 1 0.01 5.77 ANKLE FRACTURE | 1 0.01 5.78 ANKYLOSING SPONDYLITIS | 1 0.01 5.79 ANORECTAL DISCOMFORT | 1 0.01 5.80 ANOREXIA | 22 0.22 6.02 ANOSMIA | 1 0.01 6.03 ANOXIA | 1 0.01 6.04 ANOXIC ENCEPHALOPATHY | 2 0.02 6.06 ANTEPARTUM HAEMORRHAGE | 1 0.01 6.07 ANTERIOR CHAMBER DISORDER | 1 0.01 6.08 ANTI-ERYTHROPOIETIN ANTIBODY POSITIVE | 1 0.01 6.09 ANTI-GAD ANTIBODY | 1 0.01 6.10 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY .. | 3 0.03 6.13 ANTIBODY TEST POSITIVE | 1 0.01 6.14 ANTICONVULSANT DRUG LEVEL DECREASED | 1 0.01 6.15 ANTICONVULSANT DRUG LEVEL INCREASED | 1 0.01 6.16 ANTINUCLEAR ANTIBODY INCREASED | 1 0.01 6.17 ANTINUCLEAR ANTIBODY POSITIVE | 3 0.03 6.20 ANTIPHOSPHOLIPID ANTIBODIES POSITIVE | 1 0.01 6.21 ANTIPHOSPHOLIPID SYNDROME | 1 0.01 6.22 ANTIPSYCHOTIC DRUG LEVEL INCREASED | 1 0.01 6.23 ANURIA | 2 0.02 6.25 ANXIETY | 57 0.57 6.82 ANXIETY DISORDER | 1 0.01 6.83 AORTIC ANEURYSM RUPTURE | 1 0.01 6.84 AORTIC RUPTURE | 1 0.01 6.85 AORTIC VALVE SCLEROSIS | 1 0.01 6.86 APALLIC SYNDROME | 1 0.01 6.87 APATHY | 4 0.04 6.91 APHAGIA | 1 0.01 6.92 APHASIA | 1 0.01 6.93 APHONIA | 4 0.04 6.97 APHTHOUS STOMATITIS | 1 0.01 6.98 APLASIA | 1 0.01 6.99 APLASIA PURE RED CELL | 1 0.01 7.00 APLASTIC ANAEMIA | 1 0.01 7.01 APNOEA | 2 0.02 7.03 APPARENT DEATH | 1 0.01 7.04 APPENDICECTOMY | 2 0.02 7.06 APPENDICITIS | 2 0.02 7.08 APPLICATION SITE ERYTHEMA | 6 0.06 7.14 APPLICATION SITE HAEMATOMA | 1 0.01 7.15 APPLICATION SITE HYPERSENSITIVITY | 1 0.01 7.16 APPLICATION SITE IRRITATION | 6 0.06 7.22 APPLICATION SITE OEDEMA | 3 0.03 7.25 APPLICATION SITE PRURITUS | 4 0.04 7.29 APPLICATION SITE RASH | 4 0.04 7.33 APPLICATION SITE REACTION | 2 0.02 7.35 APPLICATION SITE VESICLES | 3 0.03 7.38 ARRHYTHMIA | 12 0.12 7.50 ARRHYTHMIA NEONATAL | 1 0.01 7.51 ARTERIAL DISORDER | 1 0.01 7.52 ARTERIAL OCCLUSIVE DISEASE | 7 0.07 7.59 ARTERIAL THROMBOSIS LIMB | 3 0.03 7.62 ARTERIOSCLEROSIS | 1 0.01 7.63 ARTERIOSCLEROSIS OBLITERANS | 1 0.01 7.64 ARTHRALGIA | 50 0.50 8.14 ARTHRITIS | 14 0.14 8.28 ARTHRITIS REACTIVE | 1 0.01 8.29 ARTHROPATHY | 4 0.04 8.33 ARTICULAR CALCIFICATION | 1 0.01 8.34 ASCITES | 7 0.07 8.41 ASPARTATE AMINOTRANSFERASE INCREASED | 28 0.28 8.69 ASPERGER'S DISORDER | 1 0.01 8.70 ASPHYXIA | 2 0.02 8.72 ASPIRATION | 2 0.02 8.74 ASTHENIA | 66 0.66 9.40 ASTHMA | 15 0.15 9.55 ASTHMATIC CRISIS | 1 0.01 9.56 ATAXIA | 4 0.04 9.60 ATELECTASIS | 1 0.01 9.61 ATRIAL FIBRILLATION | 14 0.14 9.75 ATRIAL FLUTTER | 4 0.04 9.79 ATRIAL SEPTAL DEFECT | 2 0.02 9.81 ATRIOVENTRICULAR BLOCK FIRST DEGREE | 1 0.01 9.82 ATRIOVENTRICULAR BLOCK SECOND DEGREE | 1 0.01 9.83 ATYPICAL MYCOBACTERIAL INFECTION | 1 0.01 9.84 AUTOIMMUNE HEPATITIS | 2 0.02 9.86 AUTONOMIC NERVOUS SYSTEM IMBALANCE | 1 0.01 9.87 AV DISSOCIATION | 1 0.01 9.88 AVOIDANT PERSONALITY DISORDER | 1 0.01 9.89 AXILLARY PAIN | 1 0.01 9.90 AXONAL NEUROPATHY | 1 0.01 9.91 BACILLUS INFECTION | 1 0.01 9.92 BACK DISORDER | 1 0.01 9.93 BACK PAIN | 39 0.39 10.32 BACTERAEMIA | 2 0.02 10.34 BACTERIA BLOOD IDENTIFIED | 1 0.01 10.35 BACTERIA SPUTUM IDENTIFIED | 1 0.01 10.36 BACTERIA URINE | 1 0.01 10.37 BACTERIA URINE IDENTIFIED | 1 0.01 10.38 BACTERIA WOUND IDENTIFIED | 1 0.01 10.39 BACTERIAL INFECTION | 3 0.03 10.42 BACTERIAL SEPSIS | 2 0.02 10.44 BALANCE DISORDER | 6 0.06 10.50 BARRETT'S OESOPHAGUS | 1 0.01 10.51 BASAL CELL CARCINOMA | 2 0.02 10.53 BASEDOW'S DISEASE | 1 0.01 10.54 BEDRIDDEN | 4 0.04 10.58 BELLIGERENCE | 1 0.01 10.59 BENIGN OVARIAN TUMOUR | 1 0.01 10.60 BENIGN PROSTATIC HYPERPLASIA | 2 0.02 10.62 BETA 2 MICROGLOBULIN INCREASED | 1 0.01 10.63 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION | 2 0.02 10.65 BILE DUCT CANCER | 1 0.01 10.66 BILE DUCT OBSTRUCTION | 2 0.02 10.68 BILE DUCT STONE | 1 0.01 10.69 BILIARY CANCER METASTATIC | 1 0.01 10.70 BILIARY CIRRHOSIS PRIMARY | 2 0.02 10.72 BILIARY COLIC | 1 0.01 10.73 BILIARY DILATATION | 1 0.01 10.74 BILIARY FISTULA | 1 0.01 10.75 BILIARY ISCHAEMIA | 1 0.01 10.76 BILIARY TRACT DISORDER | 1 0.01 10.77 BILIRUBIN CONJUGATED INCREASED | 1 0.01 10.78 BIOPSY ENDOMETRIUM ABNORMAL | 1 0.01 10.79 BIPOLAR DISORDER | 2 0.02 10.81 BIPOLAR I DISORDER | 2 0.02 10.83 BLADDER CANCER | 3 0.03 10.86 BLADDER DISORDER | 3 0.03 10.89 BLAST CELL PROLIFERATION | 1 0.01 10.90 BLEEDING TIME PROLONGED | 1 0.01 10.91 BLINDNESS | 8 0.08 10.99 BLINDNESS TRANSIENT | 1 0.01 11.00 BLINDNESS UNILATERAL | 4 0.04 11.04 BLISTER | 13 0.13 11.17 BLOOD ALBUMIN DECREASED | 8 0.08 11.25 BLOOD ALCOHOL ABNORMAL | 1 0.01 11.26 BLOOD ALKALINE PHOSPHATASE INCREASED | 11 0.11 11.37 BLOOD AMYLASE INCREASED | 5 0.05 11.42 BLOOD BICARBONATE INCREASED | 1 0.01 11.43 BLOOD BILIRUBIN INCREASED | 10 0.10 11.53 BLOOD CALCIUM ABNORMAL | 1 0.01 11.54 BLOOD CALCIUM DECREASED | 2 0.02 11.56 BLOOD CALCIUM INCREASED | 2 0.02 11.58 BLOOD CANNABINOIDS | 1 0.01 11.59 BLOOD CHOLESTEROL DECREASED | 2 0.02 11.61 BLOOD CHOLESTEROL INCREASED | 10 0.10 11.71 BLOOD COUNT ABNORMAL | 1 0.01 11.72 BLOOD CREATINE PHOSPHOKINASE INCREASED | 13 0.13 11.85 BLOOD CREATININE INCREASED | 20 0.20 12.05 BLOOD CULTURE POSITIVE | 2 0.02 12.07 BLOOD DISORDER | 4 0.04 12.11 BLOOD ELECTROLYTES ABNORMAL | 1 0.01 12.12 BLOOD FIBRINOGEN INCREASED | 2 0.02 12.14 BLOOD FOLATE DECREASED | 1 0.01 12.15 BLOOD GLUCOSE ABNORMAL | 2 0.02 12.17 BLOOD GLUCOSE DECREASED | 10 0.10 12.27 BLOOD GLUCOSE FLUCTUATION | 2 0.02 12.29 BLOOD GLUCOSE INCREASED | 25 0.25 12.54 BLOOD HUMAN CHORIONIC GONADOTROPIN AB.. | 1 0.01 12.55 BLOOD HUMAN CHORIONIC GONADOTROPIN IN.. | 3 0.03 12.58 BLOOD IMMUNOGLOBULIN E INCREASED | 1 0.01 12.59 BLOOD IMMUNOGLOBULIN M INCREASED | 1 0.01 12.60 BLOOD IRON INCREASED | 1 0.01 12.61 BLOOD KETONE BODY | 1 0.01 12.62 BLOOD LACTATE DEHYDROGENASE INCREASED | 9 0.09 12.71 BLOOD MAGNESIUM DECREASED | 1 0.01 12.72 BLOOD OSMOLARITY DECREASED | 1 0.01 12.73 BLOOD PARATHYROID HORMONE ABNORMAL | 1 0.01 12.74 BLOOD POTASSIUM DECREASED | 4 0.04 12.78 BLOOD POTASSIUM INCREASED | 4 0.04 12.82 BLOOD PRESSURE ABNORMAL | 1 0.01 12.83 BLOOD PRESSURE DECREASED | 26 0.26 13.09 BLOOD PRESSURE FLUCTUATION | 6 0.06 13.15 BLOOD PRESSURE IMMEASURABLE | 1 0.01 13.16 BLOOD PRESSURE INADEQUATELY CONTROLLED | 7 0.07 13.23 BLOOD PRESSURE INCREASED | 34 0.34 13.57 BLOOD PRESSURE SYSTOLIC DECREASED | 1 0.01 13.58 BLOOD PRESSURE SYSTOLIC INCREASED | 1 0.01 13.59 BLOOD PRODUCT TRANSFUSION | 1 0.01 13.60 BLOOD PROLACTIN INCREASED | 1 0.01 13.61 BLOOD SODIUM DECREASED | 4 0.04 13.65 BLOOD TEST ABNORMAL | 3 0.03 13.68 BLOOD THYROID STIMULATING HORMONE INC.. | 1 0.01 13.69 BLOOD TRIGLYCERIDES INCREASED | 11 0.11 13.80 BLOOD UREA DECREASED | 2 0.02 13.82 BLOOD UREA INCREASED | 8 0.08 13.90 BLOOD URIC ACID INCREASED | 2 0.02 13.92 BLOOD URINE PRESENT | 1 0.01 13.93 BLUNTED AFFECT | 2 0.02 13.95 BODY DYSMORPHIC DISORDER | 1 0.01 13.96 BODY HEIGHT ABNORMAL | 1 0.01 13.97 BODY MASS INDEX INCREASED | 1 0.01 13.98 BODY TEMPERATURE DECREASED | 2 0.02 14.00 BODY TEMPERATURE INCREASED | 9 0.09 14.09 BONE DISORDER | 4 0.04 14.13 BONE GRAFT | 1 0.01 14.14 BONE INFARCTION | 1 0.01 14.15 BONE LESION | 2 0.02 14.17 BONE MARROW FAILURE | 8 0.08 14.25 BONE PAIN | 14 0.14 14.39 BONE SARCOMA | 1 0.01 14.40 BONE SWELLING | 1 0.01 14.41 BOVINE TUBERCULOSIS | 1 0.01 14.42 BRADYARRHYTHMIA | 1 0.01 14.43 BRADYCARDIA | 10 0.10 14.53 BRADYKINESIA | 1 0.01 14.54 BRADYPHRENIA | 2 0.02 14.56 BRAIN DEATH | 1 0.01 14.57 BRAIN INJURY | 4 0.04 14.61 BRAIN NEOPLASM | 2 0.02 14.63 BRAIN OEDEMA | 2 0.02 14.65 BREAKTHROUGH PAIN | 5 0.05 14.70 BREAST CANCER | 12 0.12 14.82 BREAST CANCER FEMALE | 2 0.02 14.84 BREAST CANCER METASTATIC | 2 0.02 14.86 BREAST CANCER RECURRENT | 1 0.01 14.87 BREAST CANCER STAGE I | 1 0.01 14.88 BREAST CANCER STAGE II | 1 0.01 14.89 BREAST CYST | 1 0.01 14.90 BREAST DISCHARGE | 1 0.01 14.91 BREAST DISCOMFORT | 1 0.01 14.92 BREAST DISORDER | 1 0.01 14.93 BREAST ENLARGEMENT | 2 0.02 14.95 BREAST HYPERPLASIA | 1 0.01 14.96 BREAST MASS | 1 0.01 14.97 BREAST PAIN | 1 0.01 14.98 BREAST PROSTHESIS REMOVAL | 1 0.01 14.99 BREAST SWELLING | 2 0.02 15.01 BREAST TENDERNESS | 2 0.02 15.03 BREATH SOUNDS ABNORMAL | 1 0.01 15.04 BREATHING-RELATED SLEEP DISORDER | 1 0.01 15.05 BREECH PRESENTATION | 1 0.01 15.06 BRONCHIAL CARCINOMA | 1 0.01 15.07 BRONCHIAL OEDEMA | 1 0.01 15.08 BRONCHIAL SECRETION RETENTION | 1 0.01 15.09 BRONCHIECTASIS | 1 0.01 15.10 BRONCHITIS | 4 0.04 15.14 BRONCHITIS CHRONIC | 1 0.01 15.15 BRONCHOALVEOLAR LAVAGE | 2 0.02 15.17 BRONCHOPNEUMONIA | 3 0.03 15.20 BRONCHOPNEUMOPATHY | 1 0.01 15.21 BRONCHOPULMONARY ASPERGILLOSIS | 1 0.01 15.22 BRONCHOSCOPY | 2 0.02 15.24 BRONCHOSPASM | 5 0.05 15.29 BRUGADA SYNDROME | 2 0.02 15.31 BRUXISM | 1 0.01 15.32 BULIMIA NERVOSA | 1 0.01 15.33 BUNDLE BRANCH BLOCK RIGHT | 1 0.01 15.34 BUNION | 1 0.01 15.35 BURKITT'S LYMPHOMA | 1 0.01 15.36 BURNING MOUTH SYNDROME | 1 0.01 15.37 BURNING SENSATION | 10 0.10 15.47 BURNS SECOND DEGREE | 1 0.01 15.48 BURSITIS | 3 0.03 15.51 C-REACTIVE PROTEIN ABNORMAL | 1 0.01 15.52 C-REACTIVE PROTEIN INCREASED | 14 0.14 15.66 CACHEXIA | 1 0.01 15.67 CAESAREAN SECTION | 5 0.05 15.72 CALCINOSIS | 1 0.01 15.73 CAMPYLOBACTER INFECTION | 1 0.01 15.74 CANDIDIASIS | 4 0.04 15.78 CARBOHYDRATE ANTIGEN 125 INCREASED | 1 0.01 15.79 CARCINOEMBRYONIC ANTIGEN INCREASED | 2 0.02 15.81 CARCINOMA IN SITU | 1 0.01 15.82 CARDIAC ARREST | 30 0.30 16.12 CARDIAC DISORDER | 15 0.15 16.27 CARDIAC ENZYMES | 1 0.01 16.28 CARDIAC ENZYMES INCREASED | 1 0.01 16.29 CARDIAC FAILURE | 20 0.20 16.49 CARDIAC FAILURE ACUTE | 2 0.02 16.51 CARDIAC FAILURE CONGESTIVE | 13 0.13 16.64 CARDIAC FIBRILLATION | 2 0.02 16.66 CARDIAC HYPERTROPHY | 1 0.01 16.67 CARDIAC MURMUR | 2 0.02 16.69 CARDIAC OPERATION | 2 0.02 16.71 CARDIAC PACEMAKER INSERTION | 3 0.03 16.74 CARDIAC VALVE DISEASE | 1 0.01 16.75 CARDIO-RESPIRATORY ARREST | 15 0.15 16.90 CARDIOGENIC SHOCK | 2 0.02 16.92 CARDIOMEGALY | 6 0.06 16.98 CARDIOMYOPATHY | 3 0.03 17.01 CARDIOPULMONARY FAILURE | 1 0.01 17.02 CARDIOTOXICITY | 1 0.01 17.03 CARDIOVASCULAR DISORDER | 1 0.01 17.04 CARDIOVASCULAR INSUFFICIENCY | 1 0.01 17.05 CARDIOVERSION | 1 0.01 17.06 CAROTID ARTERY OCCLUSION | 1 0.01 17.07 CAROTID ARTERY STENOSIS | 1 0.01 17.08 CARPAL TUNNEL SYNDROME | 2 0.02 17.10 CARTILAGE INJURY | 1 0.01 17.11 CASTLEMAN'S DISEASE | 1 0.01 17.12 CAT SCRATCH DISEASE | 1 0.01 17.13 CATARACT | 9 0.09 17.22 CATARACT OPERATION | 4 0.04 17.26 CATATONIA | 2 0.02 17.28 CATHETER RELATED COMPLICATION | 3 0.03 17.31 CATHETER REMOVAL | 1 0.01 17.32 CATHETER SITE INFECTION | 1 0.01 17.33 CATHETER SITE PAIN | 1 0.01 17.34 CATHETERISATION CARDIAC | 2 0.02 17.36 CELLULITIS | 6 0.06 17.42 CENTRAL LINE INFECTION | 2 0.02 17.44 CENTRAL NERVOUS SYSTEM LESION | 1 0.01 17.45 CENTRAL VENOUS CATHETERISATION | 1 0.01 17.46 CEREBELLAR HAEMORRHAGE | 1 0.01 17.47 CEREBRAL ASPERGILLOSIS | 1 0.01 17.48 CEREBRAL ATROPHY | 1 0.01 17.49 CEREBRAL HAEMORRHAGE | 15 0.15 17.64 CEREBRAL INFARCTION | 11 0.11 17.75 CEREBRAL ISCHAEMIA | 4 0.04 17.79 CEREBROSPINAL FLUID RETENTION | 1 0.01 17.80 CEREBROVASCULAR ACCIDENT | 35 0.35 18.15 CERUMEN IMPACTION | 1 0.01 18.16 CERVIX CARCINOMA | 3 0.03 18.19 CERVIX CARCINOMA STAGE 0 | 1 0.01 18.20 CHAPPED LIPS | 1 0.01 18.21 CHEILITIS | 1 0.01 18.22 CHEST DISCOMFORT | 16 0.16 18.38 CHEST PAIN | 39 0.39 18.77 CHEST X-RAY ABNORMAL | 3 0.03 18.80 CHILLS | 17 0.17 18.97 CHLAMYDIAL INFECTION | 1 0.01 18.98 CHOANAL ATRESIA | 1 0.01 18.99 CHOKING | 2 0.02 19.01 CHOLECYSTECTOMY | 2 0.02 19.03 CHOLECYSTITIS | 3 0.03 19.06 CHOLECYSTITIS CHRONIC | 1 0.01 19.07 CHOLELITHIASIS | 11 0.11 19.18 CHOLESTASIS | 3 0.03 19.21 CHONDROMALACIA | 1 0.01 19.22 CHONDROPATHY | 1 0.01 19.23 CHORIOMENINGITIS LYMPHOCYTIC | 3 0.03 19.26 CHROMATURIA | 2 0.02 19.28 CHRONIC ALLOGRAFT NEPHROPATHY | 1 0.01 19.29 CHRONIC FATIGUE SYNDROME | 2 0.02 19.31 CHRONIC INFLAMMATORY DEMYELINATING PO.. | 1 0.01 19.32 CHRONIC LYMPHOCYTIC LEUKAEMIA | 2 0.02 19.34 CHRONIC MYELOID LEUKAEMIA | 1 0.01 19.35 CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 8 0.08 19.43 CIRCULATORY COLLAPSE | 2 0.02 19.45 CLAUSTROPHOBIA | 1 0.01 19.46 CLAVICLE FRACTURE | 1 0.01 19.47 CLONUS | 1 0.01 19.48 CLOSTRIDIAL INFECTION | 4 0.04 19.52 CLOSTRIDIUM DIFFICILE COLITIS | 3 0.03 19.55 CLUMSINESS | 1 0.01 19.56 COAGULATION TIME PROLONGED | 1 0.01 19.57 COAGULOPATHY | 1 0.01 19.58 COGNITIVE DISORDER | 3 0.03 19.61 COLD SWEAT | 4 0.04 19.65 COLECTOMY | 2 0.02 19.67 COLITIS | 3 0.03 19.70 COLITIS ISCHAEMIC | 5 0.05 19.75 COLITIS ULCERATIVE | 3 0.03 19.78 COLLAPSE OF LUNG | 1 0.01 19.79 COLON CANCER METASTATIC | 3 0.03 19.82 COLON CANCER STAGE I | 1 0.01 19.83 COLON CANCER STAGE III | 1 0.01 19.84 COLON NEOPLASM | 1 0.01 19.85 COLON OPERATION | 2 0.02 19.87 COLONIC POLYP | 1 0.01 19.88 COLORECTAL CANCER | 1 0.01 19.89 COLOSTOMY | 1 0.01 19.90 COMA | 10 0.10 20.00 COMPARTMENT SYNDROME | 1 0.01 20.01 COMPLETED SUICIDE | 18 0.18 20.19 COMPLICATION OF DEVICE INSERTION | 2 0.02 20.21 COMPLICATION OF DEVICE REMOVAL | 3 0.03 20.24 COMPLICATIONS OF TRANSPLANT SURGERY | 2 0.02 20.26 COMPLICATIONS OF TRANSPLANTED KIDNEY | 1 0.01 20.27 COMPULSIONS | 1 0.01 20.28 COMPULSIVE SHOPPING | 3 0.03 20.31 COMPUTERISED TOMOGRAM ABNORMAL | 2 0.02 20.33 CONCOMITANT DISEASE AGGRAVATED | 1 0.01 20.34 CONCUSSION | 1 0.01 20.35 CONDITION AGGRAVATED | 34 0.34 20.69 CONFUSIONAL STATE | 29 0.29 20.98 CONGENITAL ANOMALY | 2 0.02 21.00 CONGENITAL CYSTIC KIDNEY DISEASE | 1 0.01 21.01 CONGESTIVE CARDIOMYOPATHY | 1 0.01 21.02 CONJUNCTIVAL HAEMORRHAGE | 2 0.02 21.04 CONJUNCTIVAL SCAR | 1 0.01 21.05 CONJUNCTIVITIS | 6 0.06 21.11 CONJUNCTIVITIS ALLERGIC | 1 0.01 21.12 CONJUNCTIVITIS VIRAL | 1 0.01 21.13 CONSTIPATION | 33 0.33 21.46 CONTINUOUS HAEMODIAFILTRATION | 1 0.01 21.47 CONTUSION | 14 0.14 21.61 CONVERSION DISORDER | 2 0.02 21.63 CONVULSION | 48 0.48 22.11 COORDINATION ABNORMAL | 2 0.02 22.13 COPROLALIA | 1 0.01 22.14 COR PULMONALE ACUTE | 1 0.01 22.15 CORNEAL OEDEMA | 3 0.03 22.18 CORONARY ANGIOPLASTY | 1 0.01 22.19 CORONARY ARTERIAL STENT INSERTION | 2 0.02 22.21 CORONARY ARTERY BYPASS | 3 0.03 22.24 CORONARY ARTERY DISEASE | 3 0.03 22.27 CORONARY ARTERY OCCLUSION | 4 0.04 22.31 CORONARY ARTERY STENOSIS | 1 0.01 22.32 CORRECTIVE LENS USER | 1 0.01 22.33 COUGH | 23 0.23 22.56 CREATININE RENAL CLEARANCE DECREASED | 2 0.02 22.58 CREPITATIONS | 3 0.03 22.61 CROHN'S DISEASE | 4 0.04 22.65 CRYING | 7 0.07 22.72 CRYOGLOBULINAEMIA | 1 0.01 22.73 CULTURE URINE POSITIVE | 1 0.01 22.74 CUTANEOUS LUPUS ERYTHEMATOSUS | 2 0.02 22.76 CYANOSIS | 4 0.04 22.80 CYCLOTHYMIC DISORDER | 1 0.01 22.81 CYST | 3 0.03 22.84 CYST DRAINAGE | 1 0.01 22.85 CYSTITIS | 1 0.01 22.86 CYSTITIS HAEMORRHAGIC | 1 0.01 22.87 CYTOLYTIC HEPATITIS | 1 0.01 22.88 CYTOMEGALOVIRUS ANTIGEN POSITIVE | 2 0.02 22.90 CYTOMEGALOVIRUS COLITIS | 1 0.01 22.91 CYTOMEGALOVIRUS INFECTION | 1 0.01 22.92 DEAFNESS | 8 0.08 23.00 DEAFNESS NEUROSENSORY | 1 0.01 23.01 DEAFNESS UNILATERAL | 3 0.03 23.04 DEATH | 110 1.10 24.14 DEBRIDEMENT | 1 0.01 24.15 DECREASED ACTIVITY | 2 0.02 24.17 DECREASED APPETITE | 12 0.12 24.29 DECUBITUS ULCER | 2 0.02 24.31 DEEP VEIN THROMBOSIS | 14 0.14 24.45 DEFORMITY | 2 0.02 24.47 DEHYDRATION | 31 0.31 24.78 DELIRIUM | 13 0.13 24.91 DELUSION | 5 0.05 24.96 DEMENTIA | 10 0.10 25.06 DEMENTIA ALZHEIMER'S TYPE | 3 0.03 25.09 DEMYELINATING POLYNEUROPATHY | 1 0.01 25.10 DEMYELINATION | 1 0.01 25.11 DENTAL CARIES | 5 0.05 25.16 DENTURE WEARER | 1 0.01 25.17 DEPENDENCE | 1 0.01 25.18 DEPERSONALISATION | 1 0.01 25.19 DEPRESSED LEVEL OF CONSCIOUSNESS | 15 0.15 25.34 DEPRESSED MOOD | 10 0.10 25.44 DEPRESSION | 49 0.49 25.93 DEPRESSIVE SYMPTOM | 1 0.01 25.94 DEREALISATION | 1 0.01 25.95 DERMAL CYST | 1 0.01 25.96 DERMATITIS | 3 0.03 25.99 DERMATITIS ACNEIFORM | 3 0.03 26.02 DERMATITIS ALLERGIC | 1 0.01 26.03 DERMATITIS ATOPIC | 1 0.01 26.04 DERMATITIS CONTACT | 4 0.04 26.08 DERMATITIS EXFOLIATIVE | 1 0.01 26.09 DERMATOMYOSITIS | 1 0.01 26.10 DERMOID CYST | 1 0.01 26.11 DEVELOPMENTAL DELAY | 1 0.01 26.12 DEVICE BREAKAGE | 2 0.02 26.14 DEVICE FAILURE | 2 0.02 26.16 DEVICE LEAKAGE | 3 0.03 26.19 DEVICE MALFUNCTION | 4 0.04 26.23 DIABETES INSIPIDUS | 1 0.01 26.24 DIABETES MELLITUS | 15 0.15 26.39 DIABETES MELLITUS INADEQUATE CONTROL | 9 0.09 26.48 DIABETIC AUTONOMIC NEUROPATHY | 1 0.01 26.49 DIABETIC EYE DISEASE | 1 0.01 26.50 DIABETIC KETOACIDOSIS | 5 0.05 26.55 DIABETIC NEUROPATHY | 1 0.01 26.56 DIALYSIS | 4 0.04 26.60 DIAPHRAGMATIC PARALYSIS | 2 0.02 26.62 DIARRHOEA | 94 0.94 27.56 DIARRHOEA HAEMORRHAGIC | 1 0.01 27.57 DIFFERENTIAL WHITE BLOOD CELL COUNT A.. | 1 0.01 27.58 DIFFUSE LARGE B-CELL LYMPHOMA | 1 0.01 27.59 DILATATION VENTRICULAR | 3 0.03 27.62 DIPLOPIA | 2 0.02 27.64 DISABILITY | 3 0.03 27.67 DISCOMFORT | 3 0.03 27.70 DISEASE COMPLICATION | 1 0.01 27.71 DISEASE PROGRESSION | 18 0.18 27.89 DISEASE RECURRENCE | 2 0.02 27.91 DISORIENTATION | 12 0.12 28.03 DISSEMINATED INTRAVASCULAR COAGULATION | 6 0.06 28.09 DISTURBANCE IN ATTENTION | 5 0.05 28.14 DIVERTICULITIS | 5 0.05 28.19 DIVERTICULUM INTESTINAL | 2 0.02 28.21 DIZZINESS | 74 0.74 28.95 DIZZINESS EXERTIONAL | 1 0.01 28.96 DIZZINESS POSTURAL | 1 0.01 28.97 DROOLING | 3 0.03 29.00 DROP ATTACKS | 1 0.01 29.01 DRUG ABUSE | 2 0.02 29.03 DRUG ADMINISTERED AT INAPPROPRIATE SITE | 4 0.04 29.07 DRUG ADMINISTRATION ERROR | 10 0.10 29.17 DRUG DELIVERY DEVICE IMPLANTATION | 1 0.01 29.18 DRUG DEPENDENCE | 3 0.03 29.21 DRUG DISPENSING ERROR | 1 0.01 29.22 DRUG DIVERSION | 3 0.03 29.25 DRUG DOSE OMISSION | 5 0.05 29.30 DRUG EFFECT DECREASED | 7 0.07 29.37 DRUG EFFECT INCREASED | 1 0.01 29.38 DRUG ERUPTION | 5 0.05 29.43 DRUG EXPOSURE DURING PREGNANCY | 39 0.39 29.82 DRUG EXPOSURE VIA BREAST MILK | 3 0.03 29.85 DRUG HYPERSENSITIVITY | 16 0.16 30.01 DRUG INEFFECTIVE | 126 1.26 31.27 DRUG INTERACTION | 35 0.35 31.62 DRUG INTOLERANCE | 3 0.03 31.65 DRUG LEVEL CHANGED | 1 0.01 31.66 DRUG LEVEL INCREASED | 6 0.06 31.72 DRUG RASH WITH EOSINOPHILIA AND SYSTE.. | 3 0.03 31.75 DRUG RESISTANCE | 1 0.01 31.76 DRUG SCREEN POSITIVE | 4 0.04 31.80 DRUG SPECIFIC ANTIBODY PRESENT | 1 0.01 31.81 DRUG TOXICITY | 40 0.40 32.21 DRUG WITHDRAWAL SYNDROME | 8 0.08 32.29 DRUG WITHDRAWAL SYNDROME NEONATAL | 2 0.02 32.31 DRY EYE | 4 0.04 32.35 DRY MOUTH | 15 0.15 32.50 DRY SKIN | 11 0.11 32.61 DRY THROAT | 5 0.05 32.66 DUODENAL ULCER | 2 0.02 32.68 DUODENAL ULCER HAEMORRHAGE | 2 0.02 32.70 DUODENITIS | 1 0.01 32.71 DYSAESTHESIA | 1 0.01 32.72 DYSARTHRIA | 6 0.06 32.78 DYSGEUSIA | 12 0.12 32.90 DYSGRAPHIA | 1 0.01 32.91 DYSKINESIA | 13 0.13 33.04 DYSLALIA | 1 0.01 33.05 DYSMENORRHOEA | 2 0.02 33.07 DYSMORPHISM | 1 0.01 33.08 DYSPAREUNIA | 3 0.03 33.11 DYSPEPSIA | 16 0.16 33.27 DYSPHAGIA | 21 0.21 33.48 DYSPHASIA | 1 0.01 33.49 DYSPHONIA | 9 0.09 33.58 DYSPHORIA | 1 0.01 33.59 DYSPNOEA | 108 1.08 34.67 DYSPNOEA EXERTIONAL | 4 0.04 34.71 DYSSTASIA | 7 0.07 34.78 DYSTONIA | 5 0.05 34.83 DYSURIA | 8 0.08 34.91 EAR DISORDER | 1 0.01 34.92 EAR PRURITUS | 1 0.01 34.93 EATING DISORDER | 5 0.05 34.98 ECCHYMOSIS | 1 0.01 34.99 ECONOMIC PROBLEM | 4 0.04 35.03 ECTOPIC PREGNANCY WITH INTRAUTERINE D.. | 3 0.03 35.06 ECZEMA | 3 0.03 35.09 EDENTULOUS | 1 0.01 35.10 EJACULATION DISORDER | 2 0.02 35.12 EJACULATION FAILURE | 2 0.02 35.14 EJECTION FRACTION DECREASED | 5 0.05 35.19 ELECTROCARDIOGRAM ABNORMAL | 4 0.04 35.23 ELECTROCARDIOGRAM P WAVE ABNORMAL | 1 0.01 35.24 ELECTROCARDIOGRAM QT PROLONGED | 4 0.04 35.28 ELECTROCARDIOGRAM ST SEGMENT ELEVATION | 1 0.01 35.29 ELECTROCARDIOGRAM ST-T CHANGE | 1 0.01 35.30 ELECTROCARDIOGRAM T WAVE INVERSION | 3 0.03 35.33 ELECTROCONVULSIVE THERAPY | 1 0.01 35.34 ELECTROENCEPHALOGRAM ABNORMAL | 1 0.01 35.35 ELECTROLYTE IMBALANCE | 2 0.02 35.37 ELECTROMYOGRAM ABNORMAL | 1 0.01 35.38 ELEVATED MOOD | 1 0.01 35.39 EMBOLIC STROKE | 1 0.01 35.40 EMBOLISM | 3 0.03 35.43 EMOTIONAL DISORDER | 9 0.09 35.52 EMOTIONAL DISTRESS | 17 0.17 35.69 EMPHYSEMA | 4 0.04 35.73 ENAMEL ANOMALY | 1 0.01 35.74 ENANTHEMA | 1 0.01 35.75 ENCEPHALITIS | 1 0.01 35.76 ENCEPHALITIS VIRAL | 1 0.01 35.77 ENCEPHALOPATHY | 5 0.05 35.82 ENDOCARDITIS | 3 0.03 35.85 ENDODONTIC PROCEDURE | 1 0.01 35.86 ENDOMETRIAL CANCER | 1 0.01 35.87 ENDOMETRIAL CANCER STAGE III | 1 0.01 35.88 ENDOMETRIAL DISORDER | 2 0.02 35.90 ENDOPHTHALMITIS | 2 0.02 35.92 ENDOTRACHEAL INTUBATION | 2 0.02 35.94 ENDOTRACHEAL INTUBATION COMPLICATION | 1 0.01 35.95 ENGRAFTMENT SYNDROME | 1 0.01 35.96 ENLARGED CLITORIS | 1 0.01 35.97 ENTERITIS | 2 0.02 35.99 ENTEROCOCCAL INFECTION | 2 0.02 36.01 ENTEROCOLITIS | 2 0.02 36.03 EOSINOPHIL COUNT DECREASED | 1 0.01 36.04 EOSINOPHIL COUNT INCREASED | 2 0.02 36.06 EOSINOPHILIA | 1 0.01 36.07 EOSINOPHILIC PNEUMONIA | 2 0.02 36.09 EOSINOPHILIC PNEUMONIA ACUTE | 1 0.01 36.10 EPILEPSY | 5 0.05 36.15 EPISTAXIS | 13 0.13 36.28 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOP.. | 1 0.01 36.29 ERECTILE DYSFUNCTION | 8 0.08 36.37 ERECTION INCREASED | 1 0.01 36.38 EROSIVE OESOPHAGITIS | 1 0.01 36.39 ERUCTATION | 4 0.04 36.43 ERYSIPELAS | 1 0.01 36.44 ERYTHEMA | 32 0.32 36.76 ERYTHEMA MULTIFORME | 6 0.06 36.82 ERYTHEMA NODOSUM | 2 0.02 36.84 ESCHERICHIA BACTERAEMIA | 1 0.01 36.85 ESCHERICHIA INFECTION | 2 0.02 36.87 ESCHERICHIA SEPSIS | 1 0.01 36.88 EUPHORIC MOOD | 4 0.04 36.92 EXCORIATION | 3 0.03 36.95 EXOMPHALOS | 2 0.02 36.97 EXOPHTHALMOS | 1 0.01 36.98 EXPIRED DRUG ADMINISTERED | 1 0.01 36.99 EXPRESSIVE LANGUAGE DISORDER | 1 0.01 37.00 EXTRADURAL ABSCESS | 1 0.01 37.01 EXTRAPYRAMIDAL DISORDER | 4 0.04 37.05 EXTRAVASATION | 1 0.01 37.06 EXTUBATION | 1 0.01 37.07 EYE ALLERGY | 1 0.01 37.08 EYE DISCHARGE | 1 0.01 37.09 EYE DISORDER | 5 0.05 37.14 EYE HAEMORRHAGE | 4 0.04 37.18 EYE IRRITATION | 2 0.02 37.20 EYE MOVEMENT DISORDER | 1 0.01 37.21 EYE PAIN | 6 0.06 37.27 EYE PRURITUS | 4 0.04 37.31 EYE ROLLING | 1 0.01 37.32 EYE SWELLING | 10 0.10 37.42 EYELID OEDEMA | 4 0.04 37.46 EYELIDS PRURITUS | 1 0.01 37.47 FACE OEDEMA | 7 0.07 37.54 FACIAL BONES FRACTURE | 1 0.01 37.55 FACIAL PAIN | 2 0.02 37.57 FACIAL PALSY | 5 0.05 37.62 FAECAL INCONTINENCE | 8 0.08 37.70 FAECES DISCOLOURED | 5 0.05 37.75 FAILURE TO THRIVE | 3 0.03 37.78 FALL | 56 0.56 38.34 FATIGUE | 62 0.62 38.96 FEAR | 11 0.11 39.07 FEAR OF FALLING | 1 0.01 39.08 FEBRILE CONVULSION | 1 0.01 39.09 FEBRILE NEUTROPENIA | 11 0.11 39.20 FEEDING DISORDER NEONATAL | 1 0.01 39.21 FEELING ABNORMAL | 34 0.34 39.55 FEELING COLD | 13 0.13 39.68 FEELING DRUNK | 5 0.05 39.73 FEELING HOT | 12 0.12 39.85 FEELING JITTERY | 1 0.01 39.86 FEELING OF BODY TEMPERATURE CHANGE | 1 0.01 39.87 FEMALE GENITAL TRACT FISTULA | 1 0.01 39.88 FEMORAL ARTERY OCCLUSION | 1 0.01 39.89 FEMORAL NECK FRACTURE | 3 0.03 39.92 FEMUR FRACTURE | 9 0.09 40.01 FIBRIN D DIMER INCREASED | 1 0.01 40.02 FIBROADENOMA OF BREAST | 1 0.01 40.03 FIBROCYSTIC BREAST DISEASE | 1 0.01 40.04 FIBROMYALGIA | 3 0.03 40.07 FIBROSIS | 4 0.04 40.11 FIBULA AGENESIS | 1 0.01 40.12 FISTULA | 4 0.04 40.16 FLANK PAIN | 3 0.03 40.19 FLATULENCE | 7 0.07 40.26 FLIGHT OF IDEAS | 1 0.01 40.27 FLUID INTAKE REDUCED | 1 0.01 40.28 FLUID OVERLOAD | 5 0.05 40.33 FLUID RETENTION | 4 0.04 40.37 FLUSHING | 7 0.07 40.44 FOAMING AT MOUTH | 1 0.01 40.45 FOCAL SEGMENTAL GLOMERULOSCLEROSIS | 1 0.01 40.46 FOETAL ANTICONVULSANT SYNDROME | 2 0.02 40.48 FOETAL GROWTH RETARDATION | 4 0.04 40.52 FOETAL HEART RATE DISORDER | 1 0.01 40.53 FOLLICULITIS | 1 0.01 40.54 FOOD INTERACTION | 1 0.01 40.55 FOOD INTOLERANCE | 1 0.01 40.56 FOOT DEFORMITY | 2 0.02 40.58 FOOT FRACTURE | 2 0.02 40.60 FOREIGN BODY TRAUMA | 2 0.02 40.62 FORMICATION | 3 0.03 40.65 FRACTURE | 6 0.06 40.71 FRACTURED SACRUM | 1 0.01 40.72 FREQUENT BOWEL MOVEMENTS | 2 0.02 40.74 FULL BLOOD COUNT DECREASED | 1 0.01 40.75 FUNGAL INFECTION | 2 0.02 40.77 FURUNCLE | 1 0.01 40.78 GAIT DISTURBANCE | 39 0.39 41.17 GALLBLADDER DISORDER | 6 0.06 41.23 GALLBLADDER OPERATION | 2 0.02 41.25 GALLBLADDER PAIN | 1 0.01 41.26 GALLBLADDER POLYP | 1 0.01 41.27 GAMBLING | 1 0.01 41.28 GAMMA-GLUTAMYLTRANSFERASE | 1 0.01 41.29 GAMMA-GLUTAMYLTRANSFERASE INCREASED | 7 0.07 41.36 GANGRENE | 5 0.05 41.41 GARDNERELLA INFECTION | 1 0.01 41.42 GASTRIC BYPASS | 2 0.02 41.44 GASTRIC CANCER | 6 0.06 41.50 GASTRIC DISORDER | 4 0.04 41.54 GASTRIC HAEMORRHAGE | 7 0.07 41.61 GASTRIC OPERATION | 2 0.02 41.63 GASTRIC ULCER | 4 0.04 41.67 GASTRIC ULCER HAEMORRHAGE | 1 0.01 41.68 GASTRITIS | 8 0.08 41.76 GASTROENTERITIS | 6 0.06 41.82 GASTROENTERITIS RADIATION | 1 0.01 41.83 GASTROENTERITIS VIRAL | 1 0.01 41.84 GASTROINTESTINAL DISORDER | 12 0.12 41.96 GASTROINTESTINAL HAEMORRHAGE | 5 0.05 42.01 GASTROINTESTINAL INFECTION | 2 0.02 42.03 GASTROINTESTINAL INFLAMMATION | 2 0.02 42.05 GASTROINTESTINAL MOTILITY DISORDER | 3 0.03 42.08 GASTROINTESTINAL NECROSIS | 1 0.01 42.09 GASTROINTESTINAL PAIN | 1 0.01 42.10 GASTROINTESTINAL PERFORATION | 1 0.01 42.11 GASTROINTESTINAL TOXICITY | 1 0.01 42.12 GASTROOESOPHAGEAL REFLUX DISEASE | 8 0.08 42.20 GENERAL PHYSICAL HEALTH DETERIORATION | 22 0.22 42.42 GENERALISED ANXIETY DISORDER | 2 0.02 42.44 GENERALISED ERYTHEMA | 2 0.02 42.46 GENERALISED OEDEMA | 2 0.02 42.48 GENITAL HAEMORRHAGE | 11 0.11 42.59 GENITAL HERPES | 3 0.03 42.62 GENITAL PAIN | 1 0.01 42.63 GENITALIA EXTERNAL AMBIGUOUS | 1 0.01 42.64 GINGIVAL BLEEDING | 5 0.05 42.69 GINGIVAL DISORDER | 1 0.01 42.70 GINGIVAL ERYTHEMA | 2 0.02 42.72 GINGIVAL HYPERPLASIA | 1 0.01 42.73 GINGIVAL INFECTION | 1 0.01 42.74 GINGIVAL PAIN | 1 0.01 42.75 GINGIVAL SWELLING | 1 0.01 42.76 GLASGOW COMA SCALE | 1 0.01 42.77 GLASGOW COMA SCALE ABNORMAL | 1 0.01 42.78 GLAUCOMA | 2 0.02 42.80 GLOBAL AMNESIA | 1 0.01 42.81 GLOMERULAR FILTRATION RATE DECREASED | 2 0.02 42.83 GLOMERULONEPHRITIS PROLIFERATIVE | 1 0.01 42.84 GLOSSITIS | 2 0.02 42.86 GLOSSODYNIA | 3 0.03 42.89 GLUCOSE URINE PRESENT | 1 0.01 42.90 GLUTAMATE DEHYDROGENASE INCREASED | 2 0.02 42.92 GLYCOSYLATED HAEMOGLOBIN INCREASED | 2 0.02 42.94 GOITRE | 1 0.01 42.95 GONADAL DYSGENESIS | 1 0.01 42.96 GOUT | 2 0.02 42.98 GRAFT COMPLICATION | 1 0.01 42.99 GRAFT THROMBOSIS | 1 0.01 43.00 GRAFT VERSUS HOST DISEASE | 1 0.01 43.01 GRAND MAL CONVULSION | 11 0.11 43.12 GRANULOMA | 1 0.01 43.13 GROIN PAIN | 3 0.03 43.16 GROWTH OF EYELASHES | 1 0.01 43.17 GROWTH RETARDATION | 1 0.01 43.18 GYNAECOMASTIA | 3 0.03 43.21 HAEMANGIOMA | 1 0.01 43.22 HAEMATEMESIS | 6 0.06 43.28 HAEMATOCHEZIA | 7 0.07 43.35 HAEMATOCRIT DECREASED | 7 0.07 43.42 HAEMATOMA | 4 0.04 43.46 HAEMATOMA INFECTION | 1 0.01 43.47 HAEMATURIA | 6 0.06 43.53 HAEMODIALYSIS | 7 0.07 43.60 HAEMODYNAMIC INSTABILITY | 2 0.02 43.62 HAEMOGLOBIN ABNORMAL | 2 0.02 43.64 HAEMOGLOBIN DECREASED | 28 0.28 43.92 HAEMOLYSIS | 3 0.03 43.95 HAEMOLYTIC ANAEMIA | 2 0.02 43.97 HAEMOPTYSIS | 10 0.10 44.07 HAEMORRHAGE | 16 0.16 44.23 HAEMORRHAGE INTRACRANIAL | 2 0.02 44.25 HAEMORRHAGE SUBCUTANEOUS | 1 0.01 44.26 HAEMORRHAGIC CYST | 1 0.01 44.27 HAEMORRHAGIC HEPATIC CYST | 1 0.01 44.28 HAEMORRHOIDAL HAEMORRHAGE | 2 0.02 44.30 HAEMORRHOIDS | 5 0.05 44.35 HAIR COLOUR CHANGES | 2 0.02 44.37 HAIR TEXTURE ABNORMAL | 1 0.01 44.38 HALLUCINATION | 19 0.19 44.57 HALLUCINATION, AUDITORY | 4 0.04 44.61 HALLUCINATION, VISUAL | 4 0.04 44.65 HALLUCINATIONS, MIXED | 2 0.02 44.67 HAND DEFORMITY | 1 0.01 44.68 HANGOVER | 1 0.01 44.69 HEAD DEFORMITY | 1 0.01 44.70 HEAD DISCOMFORT | 1 0.01 44.71 HEAD INJURY | 4 0.04 44.75 HEADACHE | 76 0.76 45.51 HEARING IMPAIRED | 2 0.02 45.53 HEART ALTERNATION | 1 0.01 45.54 HEART INJURY | 1 0.01 45.55 HEART RATE DECREASED | 6 0.06 45.61 HEART RATE INCREASED | 11 0.11 45.72 HEART RATE IRREGULAR | 3 0.03 45.75 HEART SOUNDS ABNORMAL | 1 0.01 45.76 HEART VALVE INCOMPETENCE | 1 0.01 45.77 HELICOBACTER INFECTION | 1 0.01 45.78 HEMICEPHALALGIA | 1 0.01 45.79 HEMIPARESIS | 7 0.07 45.86 HEMIPLEGIA | 3 0.03 45.89 HENOCH-SCHONLEIN PURPURA | 3 0.03 45.92 HEPARIN-INDUCED THROMBOCYTOPENIA | 3 0.03 45.95 HEPATIC CIRRHOSIS | 5 0.05 46.00 HEPATIC CYST | 2 0.02 46.02 HEPATIC ENCEPHALOPATHY | 1 0.01 46.03 HEPATIC ENZYME INCREASED | 14 0.14 46.17 HEPATIC FAILURE | 10 0.10 46.27 HEPATIC FUNCTION ABNORMAL | 11 0.11 46.38 HEPATIC NECROSIS | 1 0.01 46.39 HEPATIC NEOPLASM | 1 0.01 46.40 HEPATIC NEOPLASM MALIGNANT | 4 0.04 46.44 HEPATIC PAIN | 1 0.01 46.45 HEPATIC STEATOSIS | 7 0.07 46.52 HEPATITIS | 8 0.08 46.60 HEPATITIS A | 1 0.01 46.61 HEPATITIS A ANTIBODY POSITIVE | 1 0.01 46.62 HEPATITIS ACUTE | 2 0.02 46.64 HEPATITIS B | 3 0.03 46.67 HEPATITIS B DNA INCREASED | 1 0.01 46.68 HEPATITIS C | 2 0.02 46.70 HEPATITIS C RNA INCREASED | 1 0.01 46.71 HEPATITIS CHOLESTATIC | 1 0.01 46.72 HEPATITIS FULMINANT | 2 0.02 46.74 HEPATITIS VIRAL | 1 0.01 46.75 HEPATO-LENTICULAR DEGENERATION | 1 0.01 46.76 HEPATOCELLULAR INJURY | 2 0.02 46.78 HEPATOMEGALY | 6 0.06 46.84 HEPATOSPLENIC T-CELL LYMPHOMA | 1 0.01 46.85 HEPATOSPLENOMEGALY | 1 0.01 46.86 HEPATOTOXICITY | 5 0.05 46.91 HERNIA OBSTRUCTIVE | 2 0.02 46.93 HERPES OESOPHAGITIS | 2 0.02 46.95 HERPES ZOSTER | 4 0.04 46.99 HIATUS HERNIA | 6 0.06 47.05 HIGH DENSITY LIPOPROTEIN DECREASED | 1 0.01 47.06 HIGH DENSITY LIPOPROTEIN INCREASED | 1 0.01 47.07 HIGH FREQUENCY ABLATION | 1 0.01 47.08 HIP ARTHROPLASTY | 3 0.03 47.11 HIP FRACTURE | 5 0.05 47.16 HOMICIDAL IDEATION | 2 0.02 47.18 HORDEOLUM | 1 0.01 47.19 HORMONE LEVEL ABNORMAL | 1 0.01 47.20 HOSPITALISATION | 8 0.08 47.28 HOT FLUSH | 4 0.04 47.32 HUMERUS FRACTURE | 2 0.02 47.34 HUNGER | 2 0.02 47.36 HUNTINGTON'S CHOREA | 1 0.01 47.37 HYDROCEPHALUS | 2 0.02 47.39 HYDRONEPHROSIS | 1 0.01 47.40 HYPERACUSIS | 2 0.02 47.42 HYPERAEMIA | 1 0.01 47.43 HYPERAESTHESIA | 1 0.01 47.44 HYPERAMMONAEMIA | 1 0.01 47.45 HYPERAMMONAEMIC ENCEPHALOPATHY | 1 0.01 47.46 HYPERBILIRUBINAEMIA | 2 0.02 47.48 HYPERCALCAEMIA | 4 0.04 47.52 HYPERCHOLESTEROLAEMIA | 2 0.02 47.54 HYPERCOAGULATION | 1 0.01 47.55 HYPEREOSINOPHILIC SYNDROME | 1 0.01 47.56 HYPERGLYCAEMIA | 12 0.12 47.68 HYPERHIDROSIS | 22 0.22 47.90 HYPERKALAEMIA | 7 0.07 47.97 HYPERKERATOSIS | 7 0.07 48.04 HYPERLIPIDAEMIA | 3 0.03 48.07 HYPERMAGNESAEMIA | 1 0.01 48.08 HYPERPARATHYROIDISM | 3 0.03 48.11 HYPERREFLEXIA | 3 0.03 48.14 HYPERSENSITIVITY | 35 0.35 48.49 HYPERSEXUALITY | 2 0.02 48.51 HYPERSOMNIA | 7 0.07 48.58 HYPERTENSION | 37 0.37 48.95 HYPERTENSIVE CRISIS | 1 0.01 48.96 HYPERTENSIVE ENCEPHALOPATHY | 1 0.01 48.97 HYPERTENSIVE HEART DISEASE | 1 0.01 48.98 HYPERTHYROIDISM | 3 0.03 49.01 HYPERTONIA | 3 0.03 49.04 HYPERTONIA NEONATAL | 1 0.01 49.05 HYPERTRIGLYCERIDAEMIA | 1 0.01 49.06 HYPERTROPHIC CARDIOMYOPATHY | 1 0.01 49.07 HYPERVENTILATION | 2 0.02 49.09 HYPERVISCOSITY SYNDROME | 1 0.01 49.10 HYPERVITAMINOSIS | 1 0.01 49.11 HYPOACUSIS | 3 0.03 49.14 HYPOAESTHESIA | 32 0.32 49.46 HYPOAESTHESIA FACIAL | 2 0.02 49.48 HYPOAESTHESIA ORAL | 6 0.06 49.54 HYPOALBUMINAEMIA | 2 0.02 49.56 HYPOCALCAEMIA | 5 0.05 49.61 HYPOGLYCAEMIA | 19 0.19 49.80 HYPOGLYCAEMIA UNAWARENESS | 1 0.01 49.81 HYPOKALAEMIA | 14 0.14 49.95 HYPOKINESIA | 4 0.04 49.99 HYPOMAGNESAEMIA | 5 0.05 50.04 HYPOMANIA | 1 0.01 50.05 HYPOMENORRHOEA | 1 0.01 50.06 HYPONATRAEMIA | 17 0.17 50.23 HYPOPHAGIA | 6 0.06 50.29 HYPOPHOSPHATAEMIA | 1 0.01 50.30 HYPOPROTEINAEMIA | 1 0.01 50.31 HYPOPYON | 1 0.01 50.32 HYPOSPADIAS | 1 0.01 50.33 HYPOTENSION | 45 0.45 50.78 HYPOTHERMIA | 3 0.03 50.81 HYPOTHYROIDISM | 7 0.07 50.88 HYPOTONIA | 1 0.01 50.89 HYPOTONIA NEONATAL | 1 0.01 50.90 HYPOVITAMINOSIS | 1 0.01 50.91 HYPOVOLAEMIA | 1 0.01 50.92 HYPOVOLAEMIC SHOCK | 2 0.02 50.94 HYPOXIA | 4 0.04 50.98 HYSTERECTOMY | 2 0.02 51.00 IATROGENIC INJURY | 1 0.01 51.01 IDIOPATHIC PNEUMONIA SYNDROME | 1 0.01 51.02 ILEITIS | 1 0.01 51.03 ILEUS | 9 0.09 51.12 ILL-DEFINED DISORDER | 19 0.19 51.31 IMMUNE RECONSTITUTION SYNDROME | 1 0.01 51.32 IMMUNE SYSTEM DISORDER | 1 0.01 51.33 IMMUNODEFICIENCY | 3 0.03 51.36 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED | 1 0.01 51.37 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED | 1 0.01 51.38 IMMUNOSUPPRESSION | 1 0.01 51.39 IMPAIRED DRIVING ABILITY | 2 0.02 51.41 IMPAIRED GASTRIC EMPTYING | 2 0.02 51.43 IMPAIRED HEALING | 4 0.04 51.47 IMPAIRED SELF-CARE | 1 0.01 51.48 IMPAIRED WORK ABILITY | 3 0.03 51.51 IMPLANT SITE INFECTION | 1 0.01 51.52 IMPRISONMENT | 2 0.02 51.54 IMPULSE-CONTROL DISORDER | 1 0.01 51.55 INADEQUATE ANALGESIA | 1 0.01 51.56 INAPPROPRIATE ANTIDIURETIC HORMONE SE.. | 10 0.10 51.66 INAPPROPRIATE SCHEDULE OF DRUG ADMINI.. | 5 0.05 51.71 INCISION SITE COMPLICATION | 1 0.01 51.72 INCISIONAL DRAINAGE | 1 0.01 51.73 INCOHERENT | 3 0.03 51.76 INCONTINENCE | 3 0.03 51.79 INCORRECT DOSE ADMINISTERED | 14 0.14 51.93 INCORRECT DRUG ADMINISTRATION DURATION | 13 0.13 52.06 INCORRECT ROUTE OF DRUG ADMINISTRATION | 15 0.15 52.21 INCREASED APPETITE | 1 0.01 52.22 INCREASED TENDENCY TO BRUISE | 2 0.02 52.24 INCUBATOR THERAPY | 1 0.01 52.25 INDURATION | 1 0.01 52.26 INFARCTION | 1 0.01 52.27 INFECTED CYST | 1 0.01 52.28 INFECTED SKIN ULCER | 1 0.01 52.29 INFECTION | 18 0.18 52.47 INFECTION PARASITIC | 1 0.01 52.48 INFERTILITY | 1 0.01 52.49 INFLAMMATION | 8 0.08 52.57 INFLAMMATION OF WOUND | 1 0.01 52.58 INFLAMMATORY BOWEL DISEASE | 3 0.03 52.61 INFLAMMATORY PAIN | 1 0.01 52.62 INFLUENZA | 6 0.06 52.68 INFLUENZA LIKE ILLNESS | 14 0.14 52.82 INFUSION RELATED REACTION | 8 0.08 52.90 INFUSION SITE ERYTHEMA | 1 0.01 52.91 INFUSION SITE PAIN | 1 0.01 52.92 INGUINAL HERNIA | 1 0.01 52.93 INHIBITORY DRUG INTERACTION | 1 0.01 52.94 INJECTION SITE ERYTHEMA | 2 0.02 52.96 INJECTION SITE INDURATION | 1 0.01 52.97 INJECTION SITE INFECTION | 1 0.01 52.98 INJECTION SITE IRRITATION | 1 0.01 52.99 INJECTION SITE NECROSIS | 1 0.01 53.00 INJECTION SITE PAIN | 7 0.07 53.07 INJECTION SITE RASH | 2 0.02 53.09 INJECTION SITE REACTION | 1 0.01 53.10 INJECTION SITE SCAB | 1 0.01 53.11 INJECTION SITE SWELLING | 4 0.04 53.15 INJECTION SITE THROMBOSIS | 1 0.01 53.16 INJURY | 16 0.16 53.32 INSOMNIA | 37 0.37 53.69 INTENTION TREMOR | 1 0.01 53.70 INTENTIONAL DRUG MISUSE | 5 0.05 53.75 INTENTIONAL OVERDOSE | 12 0.12 53.87 INTENTIONAL SELF-INJURY | 1 0.01 53.88 INTERCEPTED DRUG ADMINISTRATION ERROR | 1 0.01 53.89 INTERMITTENT CLAUDICATION | 1 0.01 53.90 INTERNATIONAL NORMALISED RATIO ABNORMAL | 2 0.02 53.92 INTERNATIONAL NORMALISED RATIO DECREA.. | 1 0.01 53.93 INTERNATIONAL NORMALISED RATIO INCREA.. | 9 0.09 54.02 INTERSTITIAL LUNG DISEASE | 10 0.10 54.12 INTERVERTEBRAL DISC DEGENERATION | 1 0.01 54.13 INTERVERTEBRAL DISC DISORDER | 1 0.01 54.14 INTERVERTEBRAL DISC PROTRUSION | 6 0.06 54.20 INTERVERTEBRAL DISCITIS | 2 0.02 54.22 INTESTINAL FISTULA | 1 0.01 54.23 INTESTINAL FUNCTIONAL DISORDER | 1 0.01 54.24 INTESTINAL HAEMORRHAGE | 2 0.02 54.26 INTESTINAL ISCHAEMIA | 1 0.01 54.27 INTESTINAL OBSTRUCTION | 14 0.14 54.41 INTESTINAL PERFORATION | 2 0.02 54.43 INTESTINAL RESECTION | 1 0.01 54.44 INTESTINAL STRANGULATION | 1 0.01 54.45 INTRA-ABDOMINAL HAEMATOMA | 2 0.02 54.47 INTRA-ABDOMINAL HAEMORRHAGE | 1 0.01 54.48 INTRA-UTERINE CONTRACEPTIVE DEVICE EX.. | 50 0.50 54.98 INTRA-UTERINE CONTRACEPTIVE DEVICE RE.. | 1 0.01 54.99 INTRA-UTERINE DEATH | 1 0.01 55.00 INTRACRANIAL HYPOTENSION | 1 0.01 55.01 INTRACRANIAL VENOUS SINUS THROMBOSIS | 2 0.02 55.03 INTRAOCULAR PRESSURE INCREASED | 3 0.03 55.06 INTRAVENTRICULAR HAEMORRHAGE | 3 0.03 55.09 INTUSSUSCEPTION | 1 0.01 55.10 INVESTIGATION ABNORMAL | 1 0.01 55.11 IRIDOCYCLITIS | 3 0.03 55.14 IRIS CONVEX | 1 0.01 55.15 IRIS DISORDER | 1 0.01 55.16 IRITIS | 2 0.02 55.18 IRON DEFICIENCY | 1 0.01 55.19 IRON DEFICIENCY ANAEMIA | 1 0.01 55.20 IRON METABOLISM DISORDER | 1 0.01 55.21 IRRITABILITY | 15 0.15 55.36 IRRITABLE BOWEL SYNDROME | 1 0.01 55.37 ISCHAEMIA | 2 0.02 55.39 ISCHAEMIC STROKE | 4 0.04 55.43 IUCD COMPLICATION | 28 0.28 55.71 IUD MIGRATION | 8 0.08 55.79 JAUNDICE | 11 0.11 55.90 JAUNDICE NEONATAL | 1 0.01 55.91 JAW DISORDER | 1 0.01 55.92 JOINT ARTHROPLASTY | 1 0.01 55.93 JOINT CONTRACTURE | 1 0.01 55.94 JOINT CREPITATION | 2 0.02 55.96 JOINT DESTRUCTION | 1 0.01 55.97 JOINT DISLOCATION | 7 0.07 56.04 JOINT EFFUSION | 2 0.02 56.06 JOINT INJURY | 2 0.02 56.08 JOINT INSTABILITY | 1 0.01 56.09 JOINT LOCK | 1 0.01 56.10 JOINT RANGE OF MOTION DECREASED | 2 0.02 56.12 JOINT STIFFNESS | 6 0.06 56.18 JOINT SWELLING | 13 0.13 56.31 JUDGEMENT IMPAIRED | 2 0.02 56.33 JUGULAR VEIN THROMBOSIS | 2 0.02 56.35 KAPOSI'S SARCOMA | 1 0.01 56.36 KERATITIS | 1 0.01 56.37 KETOACIDOSIS | 1 0.01 56.38 KETOSIS | 1 0.01 56.39 KIDNEY ENLARGEMENT | 1 0.01 56.40 KIDNEY INFECTION | 4 0.04 56.44 KIDNEY TRANSPLANT REJECTION | 1 0.01 56.45 KLEBSIELLA INFECTION | 1 0.01 56.46 KNEE ARTHROPLASTY | 5 0.05 56.51 KNEE OPERATION | 3 0.03 56.54 LABYRINTHITIS | 2 0.02 56.56 LACRIMATION INCREASED | 2 0.02 56.58 LACTIC ACIDOSIS | 4 0.04 56.62 LACTOSE INTOLERANCE | 1 0.01 56.63 LARGE INTESTINAL HAEMORRHAGE | 1 0.01 56.64 LARGE INTESTINAL ULCER HAEMORRHAGE | 1 0.01 56.65 LARGE INTESTINE PERFORATION | 4 0.04 56.69 LARYNGEAL OEDEMA | 1 0.01 56.70 LARYNGEAL OPERATION | 1 0.01 56.71 LARYNGITIS | 2 0.02 56.73 LARYNGOSPASM | 3 0.03 56.76 LEARNING DISABILITY | 1 0.01 56.77 LEFT ATRIAL DILATATION | 2 0.02 56.79 LEFT VENTRICULAR DYSFUNCTION | 1 0.01 56.80 LEFT VENTRICULAR FAILURE | 1 0.01 56.81 LEG AMPUTATION | 1 0.01 56.82 LEISHMANIASIS | 1 0.01 56.83 LETHARGY | 8 0.08 56.91 LEUCINE AMINOPEPTIDASE INCREASED | 1 0.01 56.92 LEUKAEMIA | 1 0.01 56.93 LEUKAEMIA PLASMACYTIC | 2 0.02 56.95 LEUKAEMIA RECURRENT | 1 0.01 56.96 LEUKOCYTOCLASTIC VASCULITIS | 1 0.01 56.97 LEUKOCYTOSIS | 5 0.05 57.02 LEUKOENCEPHALOPATHY | 3 0.03 57.05 LEUKOPENIA | 9 0.09 57.14 LIBIDO DECREASED | 2 0.02 57.16 LIBIDO DISORDER | 1 0.01 57.17 LICHEN PLANUS | 2 0.02 57.19 LIGAMENT INJURY | 1 0.01 57.20 LIGAMENT RUPTURE | 1 0.01 57.21 LIMB DISCOMFORT | 1 0.01 57.22 LIMB INJURY | 2 0.02 57.24 LIP BLISTER | 1 0.01 57.25 LIP DISORDER | 1 0.01 57.26 LIP DRY | 3 0.03 57.29 LIP EROSION | 1 0.01 57.30 LIP SWELLING | 5 0.05 57.35 LIP ULCERATION | 1 0.01 57.36 LIPASE INCREASED | 2 0.02 57.38 LIPODYSTROPHY ACQUIRED | 1 0.01 57.39 LIPOMA OF BREAST | 1 0.01 57.40 LIPOSARCOMA | 1 0.01 57.41 LISTLESS | 1 0.01 57.42 LIVER ABSCESS | 2 0.02 57.44 LIVER DISORDER | 18 0.18 57.62 LIVER FUNCTION TEST ABNORMAL | 14 0.14 57.76 LIVER INJURY | 4 0.04 57.80 LIVER TRANSPLANT REJECTION | 1 0.01 57.81 LIVING IN RESIDENTIAL INSTITUTION | 1 0.01 57.82 LOCAL SWELLING | 1 0.01 57.83 LOCALISED INFECTION | 7 0.07 57.90 LOGORRHOEA | 2 0.02 57.92 LOSS OF CONSCIOUSNESS | 38 0.38 58.30 LOSS OF CONTROL OF LEGS | 2 0.02 58.32 LOSS OF EMPLOYMENT | 2 0.02 58.34 LOW DENSITY LIPOPROTEIN INCREASED | 2 0.02 58.36 LOWER RESPIRATORY TRACT INFECTION | 6 0.06 58.42 LOWER RESPIRATORY TRACT INFECTION VIRAL | 1 0.01 58.43 LUMBAR SPINAL STENOSIS | 1 0.01 58.44 LUMBAR VERTEBRAL FRACTURE | 1 0.01 58.45 LUNG ABSCESS | 1 0.01 58.46 LUNG ADENOCARCINOMA | 1 0.01 58.47 LUNG CONSOLIDATION | 2 0.02 58.49 LUNG DISORDER | 9 0.09 58.58 LUNG INFECTION | 5 0.05 58.63 LUNG INFILTRATION | 2 0.02 58.65 LUNG NEOPLASM | 3 0.03 58.68 LUNG NEOPLASM MALIGNANT | 5 0.05 58.73 LUNG SQUAMOUS CELL CARCINOMA STAGE I | 1 0.01 58.74 LUPUS NEPHRITIS | 2 0.02 58.76 LUPUS-LIKE SYNDROME | 1 0.01 58.77 LYMPHADENECTOMY | 1 0.01 58.78 LYMPHADENITIS | 2 0.02 58.80 LYMPHADENOPATHY | 8 0.08 58.88 LYMPHANGIOSIS CARCINOMATOSA | 2 0.02 58.90 LYMPHOCYTE COUNT DECREASED | 1 0.01 58.91 LYMPHOCYTE COUNT INCREASED | 2 0.02 58.93 LYMPHOEDEMA | 3 0.03 58.96 LYMPHOMA | 7 0.07 59.03 LYSOZYME INCREASED | 1 0.01 59.04 MACULOPATHY | 1 0.01 59.05 MAJOR DEPRESSION | 2 0.02 59.07 MALAISE | 64 0.64 59.71 MALIGNANT BREAST LUMP REMOVAL | 1 0.01 59.72 MALIGNANT MELANOMA | 3 0.03 59.75 MALIGNANT NEOPLASM PROGRESSION | 3 0.03 59.78 MALNUTRITION | 3 0.03 59.81 MANIA | 4 0.04 59.85 MASKED FACIES | 1 0.01 59.86 MASS | 3 0.03 59.89 MASTICATION DISORDER | 1 0.01 59.90 MATERNAL CONDITION AFFECTING FOETUS | 1 0.01 59.91 MATERNAL DRUGS AFFECTING FOETUS | 4 0.04 59.95 MECHANICAL VENTILATION | 2 0.02 59.97 MEDIASTINUM NEOPLASM | 1 0.01 59.98 MEDICAL DEVICE COMPLICATION | 2 0.02 60.00 MEDICATION ERROR | 5 0.05 60.05 MEGACOLON | 1 0.01 60.06 MELAENA | 5 0.05 60.11 MELANOCYTIC NAEVUS | 1 0.01 60.12 MEMORY IMPAIRMENT | 13 0.13 60.25 MENIERE'S DISEASE | 2 0.02 60.27 MENINGITIS | 6 0.06 60.33 MENINGITIS CRYPTOCOCCAL | 1 0.01 60.34 MENINGOENCEPHALITIS HERPETIC | 1 0.01 60.35 MENISCUS LESION | 3 0.03 60.38 MENORRHAGIA | 6 0.06 60.44 MENSTRUATION DELAYED | 1 0.01 60.45 MENSTRUATION IRREGULAR | 6 0.06 60.51 MENTAL DISORDER | 8 0.08 60.59 MENTAL IMPAIRMENT | 4 0.04 60.63 MENTAL STATUS CHANGES | 5 0.05 60.68 METABOLIC ACIDOSIS | 6 0.06 60.74 METABOLIC DISORDER | 1 0.01 60.75 METASTASES TO BONE | 3 0.03 60.78 METASTASES TO LIVER | 4 0.04 60.82 METASTASES TO LYMPH NODES | 5 0.05 60.87 METASTATIC NEOPLASM | 1 0.01 60.88 METHICILLIN-RESISTANT STAPHYLOCOCCAL .. | 1 0.01 60.89 METRORRHAGIA | 1 0.01 60.90 MICROALBUMINURIA | 1 0.01 60.91 MICROANGIOPATHY | 1 0.01 60.92 MIDDLE INSOMNIA | 1 0.01 60.93 MIGRAINE | 17 0.17 61.10 MITRAL VALVE INCOMPETENCE | 1 0.01 61.11 MITRAL VALVE REPAIR | 1 0.01 61.12 MOBILITY DECREASED | 11 0.11 61.23 MONARTHRITIS | 1 0.01 61.24 MONOCYTE COUNT INCREASED | 1 0.01 61.25 MONONEUROPATHY MULTIPLEX | 1 0.01 61.26 MONOPARESIS | 2 0.02 61.28 MONOPLEGIA | 1 0.01 61.29 MOOD ALTERED | 9 0.09 61.38 MOOD SWINGS | 10 0.10 61.48 MOSAICISM | 1 0.01 61.49 MOTOR DYSFUNCTION | 6 0.06 61.55 MOUTH HAEMORRHAGE | 3 0.03 61.58 MOUTH ULCERATION | 2 0.02 61.60 MOVEMENT DISORDER | 4 0.04 61.64 MOYAMOYA DISEASE | 1 0.01 61.65 MUCOCUTANEOUS CANDIDIASIS | 1 0.01 61.66 MUCORMYCOSIS | 1 0.01 61.67 MUCOSAL DRYNESS | 3 0.03 61.70 MUCOSAL EROSION | 1 0.01 61.71 MUCOSAL INFLAMMATION | 5 0.05 61.76 MUCOUS MEMBRANE DISORDER | 3 0.03 61.79 MUCOUS STOOLS | 1 0.01 61.80 MULTI-ORGAN DISORDER | 2 0.02 61.82 MULTI-ORGAN FAILURE | 20 0.20 62.02 MULTIPLE ALLERGIES | 1 0.01 62.03 MULTIPLE CONGENITAL ABNORMALITIES | 2 0.02 62.05 MULTIPLE DRUG OVERDOSE | 5 0.05 62.10 MULTIPLE DRUG OVERDOSE INTENTIONAL | 4 0.04 62.14 MULTIPLE FRACTURES | 1 0.01 62.15 MULTIPLE INJURIES | 3 0.03 62.18 MULTIPLE MYELOMA | 1 0.01 62.19 MULTIPLE SCLEROSIS | 9 0.09 62.28 MULTIPLE SCLEROSIS RELAPSE | 8 0.08 62.36 MUSCLE ATROPHY | 2 0.02 62.38 MUSCLE CONTRACTURE | 1 0.01 62.39 MUSCLE DISORDER | 3 0.03 62.42 MUSCLE HAEMORRHAGE | 1 0.01 62.43 MUSCLE INJURY | 1 0.01 62.44 MUSCLE RIGIDITY | 2 0.02 62.46 MUSCLE RUPTURE | 1 0.01 62.47 MUSCLE SPASMS | 23 0.23 62.70 MUSCLE SPASTICITY | 1 0.01 62.71 MUSCLE TIGHTNESS | 4 0.04 62.75 MUSCLE TWITCHING | 1 0.01 62.76 MUSCULAR WEAKNESS | 25 0.25 63.01 MUSCULOSKELETAL CHEST PAIN | 5 0.05 63.06 MUSCULOSKELETAL DISORDER | 1 0.01 63.07 MUSCULOSKELETAL PAIN | 18 0.18 63.25 MUSCULOSKELETAL STIFFNESS | 8 0.08 63.33 MUTISM | 2 0.02 63.35 MYALGIA | 37 0.37 63.72 MYCOBACTERIUM AVIUM COMPLEX INFECTION | 2 0.02 63.74 MYCOSIS FUNGOIDES | 1 0.01 63.75 MYDRIASIS | 5 0.05 63.80 MYELODYSPLASTIC SYNDROME | 3 0.03 63.83 MYELOFIBROSIS | 1 0.01 63.84 MYELOPATHY | 1 0.01 63.85 MYOCARDIAL HAEMORRHAGE | 1 0.01 63.86 MYOCARDIAL INFARCTION | 41 0.41 64.27 MYOCARDIAL ISCHAEMIA | 5 0.05 64.32 MYOCARDIAL RUPTURE | 1 0.01 64.33 MYOCARDITIS | 1 0.01 64.34 MYOCLONUS | 3 0.03 64.37 MYODESOPSIA | 1 0.01 64.38 MYOPATHY | 1 0.01 64.39 MYOPIA | 1 0.01 64.40 MYOSITIS | 2 0.02 64.42 NARCOLEPSY | 1 0.01 64.43 NASAL CONGESTION | 9 0.09 64.52 NASAL DISCOMFORT | 3 0.03 64.55 NASAL DISORDER | 1 0.01 64.56 NASAL DRYNESS | 4 0.04 64.60 NASAL OEDEMA | 2 0.02 64.62 NASAL SEPTUM PERFORATION | 1 0.01 64.63 NASOPHARYNGITIS | 10 0.10 64.73 NAUSEA | 130 1.30 66.03 NECK PAIN | 7 0.07 66.10 NECROSIS | 3 0.03 66.13 NECROTISING COLITIS | 1 0.01 66.14 NECROTISING FASCIITIS | 1 0.01 66.15 NEGATIVE THOUGHTS | 1 0.01 66.16 NEGLECT OF PERSONAL APPEARANCE | 1 0.01 66.17 NEONATAL ASPHYXIA | 1 0.01 66.18 NEONATAL DISORDER | 1 0.01 66.19 NEONATAL RESPIRATORY DEPRESSION | 1 0.01 66.20 NEONATAL RESPIRATORY DISTRESS SYNDROME | 2 0.02 66.22 NEOPLASM | 2 0.02 66.24 NEOPLASM MALIGNANT | 3 0.03 66.27 NEOPLASM PROGRESSION | 5 0.05 66.32 NEOPLASM SKIN | 1 0.01 66.33 NEPHROGENIC SYSTEMIC FIBROSIS | 5 0.05 66.38 NEPHROLITHIASIS | 5 0.05 66.43 NEPHROTIC SYNDROME | 2 0.02 66.45 NERVE BLOCK | 1 0.01 66.46 NERVE INJURY | 1 0.01 66.47 NERVOUS SYSTEM DISORDER | 12 0.12 66.59 NERVOUSNESS | 12 0.12 66.71 NEURALGIA | 1 0.01 66.72 NEURECTOMY | 1 0.01 66.73 NEURODEVELOPMENTAL DISORDER | 9 0.09 66.82 NEUROGENIC BLADDER | 2 0.02 66.84 NEUROLEPTIC MALIGNANT SYNDROME | 6 0.06 66.90 NEUROLOGICAL DECOMPENSATION | 1 0.01 66.91 NEUROMYOPATHY | 1 0.01 66.92 NEUROPATHIC ULCER | 1 0.01 66.93 NEUROPATHY PERIPHERAL | 13 0.13 67.06 NEUROPSYCHIATRIC LUPUS | 1 0.01 67.07 NEUROTOXICITY | 1 0.01 67.08 NEUTROPENIA | 18 0.18 67.26 NEUTROPENIC INFECTION | 1 0.01 67.27 NEUTROPENIC SEPSIS | 3 0.03 67.30 NEUTROPHIL COUNT ABNORMAL | 2 0.02 67.32 NEUTROPHIL COUNT DECREASED | 8 0.08 67.40 NEUTROPHIL COUNT INCREASED | 6 0.06 67.46 NEUTROPHILIA | 1 0.01 67.47 NICOTINE DEPENDENCE | 2 0.02 67.49 NIEMANN-PICK DISEASE | 1 0.01 67.50 NIGHT BLINDNESS | 1 0.01 67.51 NIGHT SWEATS | 3 0.03 67.54 NIGHTMARE | 4 0.04 67.58 NO ADVERSE EVENT | 23 0.23 67.81 NO REACTION ON PREVIOUS EXPOSURE TO D.. | 1 0.01 67.82 NO THERAPEUTIC RESPONSE | 8 0.08 67.90 NOCTURIA | 3 0.03 67.93 NODAL ARRHYTHMIA | 1 0.01 67.94 NODULE | 1 0.01 67.95 NON-HODGKIN'S LYMPHOMA | 3 0.03 67.98 NON-NEUTRALISING ANTIBODIES POSITIVE | 1 0.01 67.99 NON-SMALL CELL LUNG CANCER | 2 0.02 68.01 NON-SMALL CELL LUNG CANCER STAGE IV | 1 0.01 68.02 NONSPECIFIC REACTION | 1 0.01 68.03 NORMAL NEWBORN | 1 0.01 68.04 NORMOCHROMIC NORMOCYTIC ANAEMIA | 1 0.01 68.05 NOSOCOMIAL INFECTION | 1 0.01 68.06 NUCHAL RIGIDITY | 1 0.01 68.07 NUCLEAR MAGNETIC RESONANCE IMAGING BR.. | 1 0.01 68.08 OBESITY | 2 0.02 68.10 OBLITERATIVE BRONCHIOLITIS | 1 0.01 68.11 OBSESSIVE THOUGHTS | 2 0.02 68.13 OBSESSIVE-COMPULSIVE DISORDER | 2 0.02 68.15 OBSTRUCTIVE AIRWAYS DISORDER | 1 0.01 68.16 OBSTRUCTIVE UROPATHY | 1 0.01 68.17 OCCULT BLOOD POSITIVE | 3 0.03 68.20 OCULAR DISCOMFORT | 1 0.01 68.21 OCULAR HYPERAEMIA | 7 0.07 68.28 OCULAR ICTERUS | 1 0.01 68.29 OCULOGYRIC CRISIS | 1 0.01 68.30 ODYNOPHAGIA | 1 0.01 68.31 OEDEMA | 11 0.11 68.42 OEDEMA MOUTH | 1 0.01 68.43 OEDEMA PERIPHERAL | 52 0.52 68.95 OESOPHAGEAL CARCINOMA | 1 0.01 68.96 OESOPHAGEAL FOOD IMPACTION | 1 0.01 68.97 OESOPHAGEAL PAIN | 2 0.02 68.99 OESOPHAGITIS | 3 0.03 69.02 OFF LABEL USE | 1 0.01 69.03 OLIGODIPSIA | 1 0.01 69.04 OLIGURIA | 4 0.04 69.08 ONCOLOGIC COMPLICATION | 1 0.01 69.09 ONYCHOLYSIS | 1 0.01 69.10 ONYCHOMYCOSIS | 1 0.01 69.11 OOPHORECTOMY | 1 0.01 69.12 OPEN WOUND | 1 0.01 69.13 OPIATES POSITIVE | 1 0.01 69.14 OPTIC ISCHAEMIC NEUROPATHY | 1 0.01 69.15 OPTIC NERVE DISORDER | 1 0.01 69.16 OPTIC NEURITIS | 1 0.01 69.17 OPTIC NEUROPATHY | 1 0.01 69.18 ORAL CANDIDIASIS | 2 0.02 69.20 ORAL DISCOMFORT | 4 0.04 69.24 ORAL DISORDER | 2 0.02 69.26 ORAL FUNGAL INFECTION | 2 0.02 69.28 ORAL HERPES | 2 0.02 69.30 ORAL MUCOSAL ERYTHEMA | 1 0.01 69.31 ORAL PAIN | 3 0.03 69.34 ORAL PRURITUS | 1 0.01 69.35 ORGAN FAILURE | 2 0.02 69.37 ORGANISING PNEUMONIA | 1 0.01 69.38 OROPHARYNGEAL BLISTERING | 3 0.03 69.41 OROPHARYNGEAL CANCER STAGE UNSPECIFIED | 1 0.01 69.42 OROPHARYNGEAL DISCOMFORT | 1 0.01 69.43 OROPHARYNGEAL PAIN | 10 0.10 69.53 ORTHOSTATIC HYPOTENSION | 1 0.01 69.54 OSTEITIS | 1 0.01 69.55 OSTEOARTHRITIS | 6 0.06 69.61 OSTEOLYSIS | 1 0.01 69.62 OSTEOMYELITIS | 6 0.06 69.68 OSTEOMYELITIS CHRONIC | 2 0.02 69.70 OSTEONECROSIS | 23 0.23 69.93 OSTEOPENIA | 1 0.01 69.94 OSTEOPOROSIS | 6 0.06 70.00 OTITIS MEDIA | 1 0.01 70.01 OTOSALPINGITIS | 1 0.01 70.02 OVARIAN CANCER | 2 0.02 70.04 OVARIAN CANCER METASTATIC | 1 0.01 70.05 OVARIAN CANCER RECURRENT | 1 0.01 70.06 OVARIAN CYST | 3 0.03 70.09 OVARIAN HAEMORRHAGE | 1 0.01 70.10 OVERDOSE | 24 0.24 70.34 OVERWEIGHT | 1 0.01 70.35 OXYGEN SATURATION DECREASED | 4 0.04 70.39 PAIN | 69 0.69 71.08 PAIN IN EXTREMITY | 48 0.48 71.56 PAIN IN JAW | 5 0.05 71.61 PAIN OF SKIN | 2 0.02 71.63 PAINFUL DEFAECATION | 1 0.01 71.64 PALATAL DISORDER | 1 0.01 71.65 PALLOR | 8 0.08 71.73 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SY.. | 14 0.14 71.87 PALPITATIONS | 26 0.26 72.13 PANCREATIC CARCINOMA | 5 0.05 72.18 PANCREATIC CYST | 1 0.01 72.19 PANCREATIC DISORDER | 1 0.01 72.20 PANCREATIC ENZYMES ABNORMAL | 1 0.01 72.21 PANCREATIC ENZYMES INCREASED | 1 0.01 72.22 PANCREATIC NECROSIS | 1 0.01 72.23 PANCREATITIS | 21 0.21 72.44 PANCREATITIS ACUTE | 6 0.06 72.50 PANCREATITIS NECROTISING | 1 0.01 72.51 PANCREATITIS VIRAL | 1 0.01 72.52 PANCYTOPENIA | 24 0.24 72.76 PANIC ATTACK | 10 0.10 72.86 PANIC DISORDER | 1 0.01 72.87 PANIC REACTION | 2 0.02 72.89 PANNICULITIS | 1 0.01 72.90 PARAESTHESIA | 12 0.12 73.02 PARAESTHESIA ORAL | 4 0.04 73.06 PARAINFLUENZAE VIRUS INFECTION | 1 0.01 73.07 PARALYSIS | 12 0.12 73.19 PARALYSIS FLACCID | 1 0.01 73.20 PARANOIA | 4 0.04 73.24 PARAPLEGIA | 1 0.01 73.25 PARASOMNIA | 2 0.02 73.27 PARESIS | 1 0.01 73.28 PARKINSON'S DISEASE | 1 0.01 73.29 PARKINSONISM | 4 0.04 73.33 PARONYCHIA | 1 0.01 73.34 PAROPHTHALMIA | 1 0.01 73.35 PAROSMIA | 2 0.02 73.37 PAROTID DUCT OBSTRUCTION | 1 0.01 73.38 PATENT DUCTUS ARTERIOSUS | 1 0.01 73.39 PATERNAL DRUGS AFFECTING FOETUS | 1 0.01 73.40 PATHOGEN RESISTANCE | 2 0.02 73.42 PATHOLOGICAL FRACTURE | 1 0.01 73.43 PATHOLOGICAL GAMBLING | 2 0.02 73.45 PEAU D'ORANGE | 1 0.01 73.46 PELVIC FRACTURE | 1 0.01 73.47 PELVIC MASS | 1 0.01 73.48 PELVIC PAIN | 1 0.01 73.49 PELVIC PROLAPSE | 1 0.01 73.50 PELVIC VENOUS THROMBOSIS | 1 0.01 73.51 PEMPHIGOID | 1 0.01 73.52 PERCUTANEOUS CORONARY INTERVENTION | 1 0.01 73.53 PERFORMANCE STATUS DECREASED | 2 0.02 73.55 PERIANAL ERYTHEMA | 1 0.01 73.56 PERIARTHRITIS | 1 0.01 73.57 PERICARDIAL DRAINAGE | 1 0.01 73.58 PERICARDIAL EFFUSION | 8 0.08 73.66 PERICARDITIS | 1 0.01 73.67 PERIODONTAL INFECTION | 1 0.01 73.68 PERIODONTITIS | 2 0.02 73.70 PERIORBITAL HAEMATOMA | 1 0.01 73.71 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE | 1 0.01 73.72 PERIPHERAL COLDNESS | 2 0.02 73.74 PERIPHERAL ISCHAEMIA | 1 0.01 73.75 PERIPHERAL MOTOR NEUROPATHY | 1 0.01 73.76 PERIPHERAL PARALYSIS | 1 0.01 73.77 PERIPHERAL SENSORY NEUROPATHY | 1 0.01 73.78 PERIPHERAL VASCULAR DISORDER | 2 0.02 73.80 PERITONEAL EFFUSION | 1 0.01 73.81 PERITONEAL HAEMORRHAGE | 1 0.01 73.82 PERITONEAL INFECTION | 1 0.01 73.83 PERITONITIS | 6 0.06 73.89 PERITONITIS LUPUS | 1 0.01 73.90 PERIVENTRICULAR LEUKOMALACIA | 1 0.01 73.91 PERNICIOUS ANAEMIA | 1 0.01 73.92 PERONEAL NERVE PALSY | 2 0.02 73.94 PERSONALITY CHANGE | 2 0.02 73.96 PERTUSSIS | 1 0.01 73.97 PETECHIAE | 1 0.01 73.98 PETIT MAL EPILEPSY | 2 0.02 74.00 PHARYNGEAL DISORDER | 4 0.04 74.04 PHARYNGEAL HAEMORRHAGE | 1 0.01 74.05 PHARYNGEAL HYPOAESTHESIA | 1 0.01 74.06 PHARYNGEAL OEDEMA | 6 0.06 74.12 PHARYNGITIS | 5 0.05 74.17 PHLEBITIS | 1 0.01 74.18 PHOSPHENES | 1 0.01 74.19 PHOTOPHOBIA | 1 0.01 74.20 PHYSICAL DISABILITY | 1 0.01 74.21 PHYSIOTHERAPY | 1 0.01 74.22 PIGMENTATION DISORDER | 1 0.01 74.23 PITUITARY-DEPENDENT CUSHING'S SYNDROME | 1 0.01 74.24 PLACENTA ACCRETA | 1 0.01 74.25 PLACENTAL DISORDER | 1 0.01 74.26 PLATELET COUNT ABNORMAL | 1 0.01 74.27 PLATELET COUNT DECREASED | 32 0.32 74.59 PLATELET COUNT INCREASED | 3 0.03 74.62 PLEURAL EFFUSION | 21 0.21 74.83 PLEURISY | 2 0.02 74.85 PLEURODESIS | 1 0.01 74.86 PNEUMOCYSTIS JIROVECI INFECTION | 1 0.01 74.87 PNEUMOCYSTIS JIROVECI PNEUMONIA | 4 0.04 74.91 PNEUMONIA | 74 0.74 75.65 PNEUMONIA ASPIRATION | 14 0.14 75.79 PNEUMONIA CHLAMYDIAL | 1 0.01 75.80 PNEUMONIA CRYPTOCOCCAL | 1 0.01 75.81 PNEUMONIA FUNGAL | 1 0.01 75.82 PNEUMONIA LEGIONELLA | 1 0.01 75.83 PNEUMONIA PNEUMOCOCCAL | 1 0.01 75.84 PNEUMONIA PRIMARY ATYPICAL | 1 0.01 75.85 PNEUMONIA STAPHYLOCOCCAL | 1 0.01 75.86 PNEUMONIA STREPTOCOCCAL | 2 0.02 75.88 PNEUMONITIS | 6 0.06 75.94 PNEUMOTHORAX | 5 0.05 75.99 PO2 DECREASED | 1 0.01 76.00 POISONING | 4 0.04 76.04 POLLAKIURIA | 8 0.08 76.12 POLYCYTHAEMIA | 2 0.02 76.14 POLYMENORRHOEA | 2 0.02 76.16 POLYNEUROPATHY | 1 0.01 76.17 POLYP | 3 0.03 76.20 POOR DENTAL CONDITION | 1 0.01 76.21 POOR QUALITY SLEEP | 4 0.04 76.25 PORIOMANIA | 1 0.01 76.26 PORPHYRIA ACUTE | 1 0.01 76.27 PORTAL HYPERTENSION | 1 0.01 76.28 PORTAL VEIN THROMBOSIS | 1 0.01 76.29 POST PROCEDURAL COMPLICATION | 5 0.05 76.34 POST PROCEDURAL DISCHARGE | 1 0.01 76.35 POST PROCEDURAL HAEMORRHAGE | 7 0.07 76.42 POST PROCEDURAL INFECTION | 3 0.03 76.45 POSTERIOR CAPSULE OPACIFICATION | 2 0.02 76.47 POSTOPERATIVE WOUND COMPLICATION | 1 0.01 76.48 POSTOPERATIVE WOUND INFECTION | 5 0.05 76.53 POSTPARTUM DEPRESSION | 1 0.01 76.54 POSTURE ABNORMAL | 2 0.02 76.56 PRE-ECLAMPSIA | 1 0.01 76.57 PRECANCEROUS CELLS PRESENT | 1 0.01 76.58 PRECOCIOUS PUBERTY | 1 0.01 76.59 PREDISPOSITION TO DISEASE | 1 0.01 76.60 PREGNANCY | 13 0.13 76.73 PREGNANCY ON CONTRACEPTIVE | 1 0.01 76.74 PREGNANCY ON ORAL CONTRACEPTIVE | 1 0.01 76.75 PREGNANCY TEST POSITIVE | 1 0.01 76.76 PREGNANCY WITH CONTRACEPTIVE DEVICE | 9 0.09 76.85 PREGNANCY WITH IMPLANT CONTRACEPTIVE | 1 0.01 76.86 PREMATURE BABY | 5 0.05 76.91 PREMATURE LABOUR | 3 0.03 76.94 PREMATURE RUPTURE OF MEMBRANES | 3 0.03 76.97 PREMATURE SEPARATION OF PLACENTA | 2 0.02 76.99 PRESBYOPIA | 1 0.01 77.00 PRESYNCOPE | 3 0.03 77.03 PRIAPISM | 2 0.02 77.05 PRIMARY SEQUESTRUM | 2 0.02 77.07 PROCEDURAL COMPLICATION | 1 0.01 77.08 PROCEDURAL HYPERTENSION | 1 0.01 77.09 PROCEDURAL PAIN | 8 0.08 77.17 PROCTALGIA | 3 0.03 77.20 PROCTITIS | 1 0.01 77.21 PROCTITIS ULCERATIVE | 1 0.01 77.22 PRODUCT CONTAMINATION | 1 0.01 77.23 PRODUCT COUNTERFEIT | 1 0.01 77.24 PRODUCT QUALITY ISSUE | 64 0.64 77.88 PRODUCT TAMPERING | 1 0.01 77.89 PRODUCTIVE COUGH | 4 0.04 77.93 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALO.. | 2 0.02 77.95 PROPHYLAXIS | 1 0.01 77.96 PROSTATE CANCER | 3 0.03 77.99 PROSTATIC DISORDER | 1 0.01 78.00 PROSTATIC OPERATION | 1 0.01 78.01 PROSTATIC SPECIFIC ANTIGEN INCREASED | 2 0.02 78.03 PROSTATOMEGALY | 1 0.01 78.04 PROTEIN TOTAL DECREASED | 3 0.03 78.07 PROTEIN TOTAL INCREASED | 1 0.01 78.08 PROTEIN URINE PRESENT | 3 0.03 78.11 PROTEINURIA | 7 0.07 78.18 PROTHROMBIN LEVEL INCREASED | 1 0.01 78.19 PROTHROMBIN TIME PROLONGED | 2 0.02 78.21 PRURITUS | 43 0.43 78.64 PRURITUS GENERALISED | 8 0.08 78.72 PSEUDOMEMBRANOUS COLITIS | 1 0.01 78.73 PSEUDOMONAL SEPSIS | 1 0.01 78.74 PSEUDOMONAS INFECTION | 1 0.01 78.75 PSOAS ABSCESS | 1 0.01 78.76 PSORIASIS | 2 0.02 78.78 PSORIATIC ARTHROPATHY | 1 0.01 78.79 PSYCHIATRIC DECOMPENSATION | 1 0.01 78.80 PSYCHIATRIC SYMPTOM | 5 0.05 78.85 PSYCHOMOTOR HYPERACTIVITY | 5 0.05 78.90 PSYCHOTIC DISORDER | 11 0.11 79.01 PULMONARY CALCIFICATION | 1 0.01 79.02 PULMONARY CONGESTION | 4 0.04 79.06 PULMONARY EMBOLISM | 33 0.33 79.39 PULMONARY FIBROSIS | 7 0.07 79.46 PULMONARY HAEMORRHAGE | 3 0.03 79.49 PULMONARY HYPERTENSION | 6 0.06 79.55 PULMONARY INFARCTION | 2 0.02 79.57 PULMONARY MALFORMATION | 1 0.01 79.58 PULMONARY MASS | 2 0.02 79.60 PULMONARY MYCOSIS | 1 0.01 79.61 PULMONARY OEDEMA | 11 0.11 79.72 PULMONARY SARCOIDOSIS | 1 0.01 79.73 PULMONARY THROMBOSIS | 3 0.03 79.76 PULMONARY TUBERCULOSIS | 2 0.02 79.78 PULMONARY VEIN STENOSIS | 1 0.01 79.79 PULSE ABSENT | 1 0.01 79.80 PUPIL FIXED | 1 0.01 79.81 PURE WHITE CELL APLASIA | 1 0.01 79.82 PURPURA | 1 0.01 79.83 PURULENT DISCHARGE | 2 0.02 79.85 PYELONEPHRITIS | 2 0.02 79.87 PYODERMA GANGRENOSUM | 2 0.02 79.89 PYREXIA | 91 0.91 80.80 QUADRIPARESIS | 1 0.01 80.81 QUALITY OF LIFE DECREASED | 2 0.02 80.83 RADIATION NECROSIS | 1 0.01 80.84 RADICULAR PAIN | 1 0.01 80.85 RADICULOPATHY | 1 0.01 80.86 RADIOGRAPHY GUIDED ASPIRATION | 1 0.01 80.87 RADIOTHERAPY | 1 0.01 80.88 RASH | 68 0.68 81.56 RASH ERYTHEMATOUS | 4 0.04 81.60 RASH GENERALISED | 7 0.07 81.67 RASH MACULAR | 3 0.03 81.70 RASH MACULO-PAPULAR | 5 0.05 81.75 RASH PAPULAR | 3 0.03 81.78 RASH PRURITIC | 3 0.03 81.81 RASH PUSTULAR | 3 0.03 81.84 RASH VESICULAR | 4 0.04 81.88 RECTAL CANCER | 1 0.01 81.89 RECTAL HAEMORRHAGE | 16 0.16 82.05 RECTAL PERFORATION | 1 0.01 82.06 RECTOCELE | 1 0.01 82.07 RED BLOOD CELL COUNT DECREASED | 7 0.07 82.14 RED BLOOD CELL SEDIMENTATION RATE INC.. | 4 0.04 82.18 REFLEXES ABNORMAL | 1 0.01 82.19 REFLUX OESOPHAGITIS | 1 0.01 82.20 REFRACTORY ANAEMIA WITH AN EXCESS OF .. | 1 0.01 82.21 REFUSAL OF TREATMENT BY PATIENT | 1 0.01 82.22 REGRESSIVE BEHAVIOUR | 1 0.01 82.23 REGURGITATION | 1 0.01 82.24 REHABILITATION THERAPY | 1 0.01 82.25 REITER'S SYNDROME | 4 0.04 82.29 RENAL CELL CARCINOMA | 4 0.04 82.33 RENAL COLIC | 1 0.01 82.34 RENAL CORTICAL NECROSIS | 1 0.01 82.35 RENAL CYST | 3 0.03 82.38 RENAL DISORDER | 9 0.09 82.47 RENAL DYSPLASIA | 1 0.01 82.48 RENAL FAILURE | 42 0.42 82.90 RENAL FAILURE ACUTE | 38 0.38 83.28 RENAL FAILURE CHRONIC | 2 0.02 83.30 RENAL FUNCTION TEST ABNORMAL | 2 0.02 83.32 RENAL IMPAIRMENT | 32 0.32 83.64 RENAL INFARCT | 1 0.01 83.65 RENAL INJURY | 8 0.08 83.73 RENAL MASS | 1 0.01 83.74 RENAL PAIN | 2 0.02 83.76 RENAL TUBULAR NECROSIS | 5 0.05 83.81 RENAL VASCULITIS | 1 0.01 83.82 RESORPTION BONE INCREASED | 2 0.02 83.84 RESPIRATION ABNORMAL | 1 0.01 83.85 RESPIRATORY ACIDOSIS | 2 0.02 83.87 RESPIRATORY ARREST | 9 0.09 83.96 RESPIRATORY DEPRESSION | 3 0.03 83.99 RESPIRATORY DISORDER | 9 0.09 84.08 RESPIRATORY DISORDER NEONATAL | 1 0.01 84.09 RESPIRATORY DISTRESS | 1 0.01 84.10 RESPIRATORY FAILURE | 23 0.23 84.33 RESPIRATORY SYNCYTIAL VIRUS INFECTION | 2 0.02 84.35 RESPIRATORY TRACT CONGESTION | 1 0.01 84.36 RESPIRATORY TRACT INFECTION | 4 0.04 84.40 RESTLESS LEGS SYNDROME | 2 0.02 84.42 RESTLESSNESS | 10 0.10 84.52 RESUSCITATION | 3 0.03 84.55 RETCHING | 3 0.03 84.58 RETINAL DETACHMENT | 6 0.06 84.64 RETINAL DISORDER | 2 0.02 84.66 RETINAL EXUDATES | 1 0.01 84.67 RETINAL HAEMORRHAGE | 4 0.04 84.71 RETINAL ISCHAEMIA | 1 0.01 84.72 RETINAL OEDEMA | 1 0.01 84.73 RETINAL PIGMENT EPITHELIAL TEAR | 1 0.01 84.74 RETINAL PIGMENT EPITHELIOPATHY | 1 0.01 84.75 RETINAL VEIN THROMBOSIS | 2 0.02 84.77 RETINOPATHY | 11 0.11 84.88 RETROGRADE EJACULATION | 1 0.01 84.89 RETROPERITONEAL HAEMATOMA | 1 0.01 84.90 RETROPERITONEAL HAEMORRHAGE | 2 0.02 84.92 RETROPERITONEAL INFECTION | 1 0.01 84.93 RHABDOMYOLYSIS | 7 0.07 85.00 RHEUMATOID ARTHRITIS | 10 0.10 85.10 RHEUMATOID NODULE | 1 0.01 85.11 RHINORRHOEA | 5 0.05 85.16 RIB FRACTURE | 3 0.03 85.19 RIGHT VENTRICULAR FAILURE | 1 0.01 85.20 ROAD TRAFFIC ACCIDENT | 14 0.14 85.34 ROSACEA | 1 0.01 85.35 ROTATOR CUFF SYNDROME | 5 0.05 85.40 RUPTURED CEREBRAL ANEURYSM | 1 0.01 85.41 RUPTURED ECTOPIC PREGNANCY | 1 0.01 85.42 SACROILIITIS | 1 0.01 85.43 SALIVARY GLAND DISORDER | 1 0.01 85.44 SALIVARY HYPERSECRETION | 4 0.04 85.48 SALPINGO-OOPHORECTOMY BILATERAL | 1 0.01 85.49 SARCOIDOSIS | 2 0.02 85.51 SARCOMA UTERUS | 2 0.02 85.53 SCAR | 6 0.06 85.59 SCHAMBERG'S DISEASE | 1 0.01 85.60 SCHIZOPHRENIA | 5 0.05 85.65 SCHIZOPHRENIFORM DISORDER | 1 0.01 85.66 SCIATICA | 1 0.01 85.67 SCLERODERMA | 1 0.01 85.68 SCOLIOSIS | 1 0.01 85.69 SCRATCH | 1 0.01 85.70 SCROTAL ERYTHEMA | 2 0.02 85.72 SCROTAL OEDEMA | 2 0.02 85.74 SCROTAL PAIN | 1 0.01 85.75 SCROTAL SWELLING | 2 0.02 85.77 SCROTAL ULCER | 1 0.01 85.78 SEBORRHOEIC DERMATITIS | 1 0.01 85.79 SECRETION DISCHARGE | 2 0.02 85.81 SEDATION | 4 0.04 85.85 SEGMENTED HYALINISING VASCULITIS | 1 0.01 85.86 SELECTIVE ABORTION | 1 0.01 85.87 SELF INJURIOUS BEHAVIOUR | 2 0.02 85.89 SELF-INJURIOUS IDEATION | 2 0.02 85.91 SELF-MEDICATION | 1 0.01 85.92 SEMEN ANALYSIS ABNORMAL | 1 0.01 85.93 SEMEN VOLUME DECREASED | 1 0.01 85.94 SENSATION OF FOREIGN BODY | 1 0.01 85.95 SENSATION OF HEAVINESS | 4 0.04 85.99 SENSATION OF PRESSURE | 2 0.02 86.01 SENSORY DISTURBANCE | 3 0.03 86.04 SENSORY LOSS | 3 0.03 86.07 SEPSIS | 33 0.33 86.40 SEPTIC ARTHRITIS STAPHYLOCOCCAL | 1 0.01 86.41 SEPTIC SHOCK | 10 0.10 86.51 SEQUESTRECTOMY | 2 0.02 86.53 SEROTONIN SYNDROME | 2 0.02 86.55 SERUM FERRITIN INCREASED | 1 0.01 86.56 SERUM SICKNESS | 1 0.01 86.57 SEXUAL ABUSE | 2 0.02 86.59 SHOCK | 10 0.10 86.69 SHOCK HAEMORRHAGIC | 2 0.02 86.71 SHORT-BOWEL SYNDROME | 1 0.01 86.72 SHUNT THROMBOSIS | 1 0.01 86.73 SICK SINUS SYNDROME | 2 0.02 86.75 SINUS ARREST | 2 0.02 86.77 SINUS ARRHYTHMIA | 1 0.01 86.78 SINUS BRADYCARDIA | 1 0.01 86.79 SINUS HEADACHE | 1 0.01 86.80 SINUS TACHYCARDIA | 4 0.04 86.84 SINUSITIS | 4 0.04 86.88 SINUSITIS ASPERGILLUS | 1 0.01 86.89 SKELETAL INJURY | 2 0.02 86.91 SKIN BURNING SENSATION | 3 0.03 86.94 SKIN CANCER | 1 0.01 86.95 SKIN DEPIGMENTATION | 2 0.02 86.97 SKIN DISCOLOURATION | 5 0.05 87.02 SKIN DISORDER | 3 0.03 87.05 SKIN EROSION | 1 0.01 87.06 SKIN EXFOLIATION | 11 0.11 87.17 SKIN FIBROSIS | 3 0.03 87.20 SKIN HAEMORRHAGE | 1 0.01 87.21 SKIN HYPERPIGMENTATION | 2 0.02 87.23 SKIN HYPERTROPHY | 1 0.01 87.24 SKIN INDURATION | 2 0.02 87.26 SKIN INFECTION | 2 0.02 87.28 SKIN INJURY | 1 0.01 87.29 SKIN IRRITATION | 3 0.03 87.32 SKIN LACERATION | 2 0.02 87.34 SKIN LESION | 4 0.04 87.38 SKIN NECROSIS | 3 0.03 87.41 SKIN NODULE | 2 0.02 87.43 SKIN PAPILLOMA | 1 0.01 87.44 SKIN REACTION | 7 0.07 87.51 SKIN STRIAE | 2 0.02 87.53 SKIN SWELLING | 1 0.01 87.54 SKIN TIGHTNESS | 2 0.02 87.56 SKIN TOXICITY | 1 0.01 87.57 SKIN ULCER | 5 0.05 87.62 SKIN ULCER HAEMORRHAGE | 1 0.01 87.63 SKIN WARM | 2 0.02 87.65 SKULL FRACTURE | 1 0.01 87.66 SLEEP APNOEA SYNDROME | 3 0.03 87.69 SLEEP DISORDER | 10 0.10 87.79 SLEEP SEX | 1 0.01 87.80 SMALL CELL LUNG CANCER METASTATIC | 1 0.01 87.81 SMALL CELL LUNG CANCER STAGE UNSPECIF.. | 1 0.01 87.82 SMALL FOR DATES BABY | 3 0.03 87.85 SMALL INTESTINAL HAEMORRHAGE | 2 0.02 87.87 SMALL INTESTINE ULCER | 1 0.01 87.88 SMEAR CERVIX ABNORMAL | 5 0.05 87.93 SNEEZING | 3 0.03 87.96 SOCIAL AVOIDANT BEHAVIOUR | 1 0.01 87.97 SOCIAL PROBLEM | 3 0.03 88.00 SOFT TISSUE INFECTION | 2 0.02 88.02 SOFT TISSUE INJURY | 1 0.01 88.03 SOMATISATION DISORDER | 1 0.01 88.04 SOMNAMBULISM | 7 0.07 88.11 SOMNOLENCE | 32 0.32 88.43 SPEECH DISORDER | 22 0.22 88.65 SPEECH DISORDER DEVELOPMENTAL | 3 0.03 88.68 SPIDER NAEVUS | 1 0.01 88.69 SPINAL COLUMN STENOSIS | 3 0.03 88.72 SPINAL COMPRESSION FRACTURE | 1 0.01 88.73 SPINAL CORD COMPRESSION | 1 0.01 88.74 SPINAL CORD OPERATION | 1 0.01 88.75 SPINAL DISORDER | 6 0.06 88.81 SPINAL FRACTURE | 2 0.02 88.83 SPINAL FUSION SURGERY | 2 0.02 88.85 SPINAL LAMINECTOMY | 1 0.01 88.86 SPINAL OPERATION | 1 0.01 88.87 SPINAL OSTEOARTHRITIS | 2 0.02 88.89 SPLENIC CYST | 1 0.01 88.90 SPLENIC INFARCTION | 1 0.01 88.91 SPLENOMEGALY | 5 0.05 88.96 SPONDYLITIS | 1 0.01 88.97 SPONDYLOLISTHESIS | 1 0.01 88.98 SPONTANEOUS PENILE ERECTION | 1 0.01 88.99 SPUTUM DISCOLOURED | 1 0.01 89.00 SPUTUM RETENTION | 1 0.01 89.01 SQUAMOUS CELL CARCINOMA OF SKIN | 1 0.01 89.02 STAPHYLOCOCCAL BACTERAEMIA | 1 0.01 89.03 STAPHYLOCOCCAL INFECTION | 11 0.11 89.14 STAPHYLOCOCCAL OSTEOMYELITIS | 1 0.01 89.15 STAPHYLOCOCCAL SEPSIS | 2 0.02 89.17 STATUS EPILEPTICUS | 6 0.06 89.23 STENT OCCLUSION | 2 0.02 89.25 STENT PLACEMENT | 5 0.05 89.30 STERNAL FRACTURE | 2 0.02 89.32 STEVENS-JOHNSON SYNDROME | 8 0.08 89.40 STOMATITIS | 8 0.08 89.48 STRABISMUS | 1 0.01 89.49 STREPTOCOCCAL INFECTION | 1 0.01 89.50 STRESS | 13 0.13 89.63 STRESS CARDIOMYOPATHY | 1 0.01 89.64 STRESS FRACTURE | 1 0.01 89.65 STUPOR | 2 0.02 89.67 SUBARACHNOID HAEMORRHAGE | 3 0.03 89.70 SUBCUTANEOUS ABSCESS | 1 0.01 89.71 SUBCUTANEOUS HAEMATOMA | 1 0.01 89.72 SUBCUTANEOUS NODULE | 1 0.01 89.73 SUBDURAL HAEMATOMA | 5 0.05 89.78 SUBSTANCE ABUSE | 2 0.02 89.80 SUDDEN DEATH | 7 0.07 89.87 SUFFOCATION FEELING | 1 0.01 89.88 SUICIDAL BEHAVIOUR | 3 0.03 89.91 SUICIDAL IDEATION | 26 0.26 90.17 SUICIDE ATTEMPT | 14 0.14 90.31 SUNBURN | 1 0.01 90.32 SUPERIOR SAGITTAL SINUS THROMBOSIS | 2 0.02 90.34 SUPRAVENTRICULAR EXTRASYSTOLES | 3 0.03 90.37 SURGERY | 9 0.09 90.46 SWEAT GLAND INFECTION | 1 0.01 90.47 SWELLING | 10 0.10 90.57 SWELLING FACE | 12 0.12 90.69 SWOLLEN TONGUE | 12 0.12 90.81 SYMBLEPHARON | 1 0.01 90.82 SYNCOPE | 27 0.27 91.09 SYNDACTYLY | 1 0.01 91.10 SYNOVIAL CYST | 1 0.01 91.11 SYPHILIS TEST | 1 0.01 91.12 SYSTEMIC LUPUS ERYTHEMATOSUS | 5 0.05 91.17 SYSTOLIC HYPERTENSION | 1 0.01 91.18 TACHYCARDIA | 23 0.23 91.41 TACHYCARDIA FOETAL | 1 0.01 91.42 TACHYCARDIA PAROXYSMAL | 1 0.01 91.43 TACHYPHRENIA | 2 0.02 91.45 TACHYPNOEA | 2 0.02 91.47 TALIPES | 1 0.01 91.48 TARDIVE DYSKINESIA | 2 0.02 91.50 TEARFULNESS | 1 0.01 91.51 TENDERNESS | 1 0.01 91.52 TENDON DISORDER | 3 0.03 91.55 TENDON INJURY | 2 0.02 91.57 TENDON PAIN | 7 0.07 91.64 TENDON RUPTURE | 3 0.03 91.67 TENDONITIS | 3 0.03 91.70 TENOSYNOVITIS STENOSANS | 1 0.01 91.71 TENSION | 5 0.05 91.76 TESTICULAR FAILURE | 1 0.01 91.77 TESTICULAR PAIN | 1 0.01 91.78 TESTIS CANCER | 1 0.01 91.79 THERAPEUTIC AGENT TOXICITY | 5 0.05 91.84 THERAPEUTIC ASPIRATION | 1 0.01 91.85 THERAPEUTIC EMBOLISATION | 1 0.01 91.86 THERAPEUTIC PROCEDURE | 1 0.01 91.87 THERAPEUTIC RESPONSE DECREASED | 6 0.06 91.93 THERAPEUTIC RESPONSE DELAYED | 1 0.01 91.94 THERAPEUTIC RESPONSE UNEXPECTED WITH .. | 9 0.09 92.03 THERAPY CESSATION | 2 0.02 92.05 THINKING ABNORMAL | 6 0.06 92.11 THORACIC CAVITY DRAINAGE | 1 0.01 92.12 THREATENED LABOUR | 1 0.01 92.13 THROAT CANCER | 2 0.02 92.15 THROAT IRRITATION | 7 0.07 92.22 THROAT TIGHTNESS | 6 0.06 92.28 THROMBOCYTHAEMIA | 2 0.02 92.30 THROMBOCYTOPENIA | 26 0.26 92.56 THROMBOPHLEBITIS SEPTIC | 1 0.01 92.57 THROMBOPHLEBITIS SUPERFICIAL | 1 0.01 92.58 THROMBOSIS | 7 0.07 92.65 THROMBOTIC THROMBOCYTOPENIC PURPURA | 3 0.03 92.68 THYMOMA | 1 0.01 92.69 THYROID CANCER | 2 0.02 92.71 THYROID DISORDER | 1 0.01 92.72 THYROID FUNCTION TEST ABNORMAL | 12 0.12 92.84 THYROID NEOPLASM | 1 0.01 92.85 THYROIDITIS | 1 0.01 92.86 THYROXINE FREE DECREASED | 1 0.01 92.87 TIBIA FRACTURE | 1 0.01 92.88 TIC | 2 0.02 92.90 TINEA PEDIS | 1 0.01 92.91 TINNITUS | 12 0.12 93.03 TOBACCO POISONING | 1 0.01 93.04 TOE AMPUTATION | 1 0.01 93.05 TONGUE BLISTERING | 1 0.01 93.06 TONGUE COATED | 2 0.02 93.08 TONGUE DISCOLOURATION | 1 0.01 93.09 TONGUE DISORDER | 2 0.02 93.11 TONGUE DRY | 1 0.01 93.12 TONGUE NEOPLASM MALIGNANT STAGE UNSPE.. | 1 0.01 93.13 TONGUE OEDEMA | 1 0.01 93.14 TONGUE ULCERATION | 1 0.01 93.15 TONIC CLONIC MOVEMENTS | 1 0.01 93.16 TONSILLITIS | 1 0.01 93.17 TOOTH DEPOSIT | 2 0.02 93.19 TOOTH DISORDER | 4 0.04 93.23 TOOTH EXTRACTION | 3 0.03 93.26 TOOTH INFECTION | 1 0.01 93.27 TOOTH INJURY | 1 0.01 93.28 TOOTH LOSS | 1 0.01 93.29 TOOTHACHE | 4 0.04 93.33 TORSADE DE POINTES | 1 0.01 93.34 TOXIC ENCEPHALOPATHY | 4 0.04 93.38 TOXIC EPIDERMAL NECROLYSIS | 5 0.05 93.43 TOXIC SHOCK SYNDROME | 1 0.01 93.44 TOXIC SKIN ERUPTION | 1 0.01 93.45 TRABECULOPLASTY | 1 0.01 93.46 TRACHEAL OEDEMA | 1 0.01 93.47 TRACHEOSTOMY | 1 0.01 93.48 TRANSAMINASES INCREASED | 6 0.06 93.54 TRANSIENT ISCHAEMIC ATTACK | 5 0.05 93.59 TRANSIENT TACHYPNOEA OF THE NEWBORN | 1 0.01 93.60 TRANSPLANT REJECTION | 1 0.01 93.61 TRANSPOSITION OF THE GREAT VESSELS | 1 0.01 93.62 TRANSURETHRAL PROSTATECTOMY | 1 0.01 93.63 TRAUMATIC BRAIN INJURY | 2 0.02 93.65 TRAUMATIC HAEMATOMA | 1 0.01 93.66 TREATMENT FAILURE | 5 0.05 93.71 TREATMENT NONCOMPLIANCE | 9 0.09 93.80 TREMOR | 31 0.31 94.11 TRICHOSPORON INFECTION | 1 0.01 94.12 TRICHOTILLOMANIA | 1 0.01 94.13 TRICUSPID VALVE INCOMPETENCE | 1 0.01 94.14 TRIGGER FINGER | 2 0.02 94.16 TRISMUS | 1 0.01 94.17 TROPONIN INCREASED | 1 0.01 94.18 TROPONIN T INCREASED | 1 0.01 94.19 TUBERCULOSIS | 4 0.04 94.23 TUBULOINTERSTITIAL NEPHRITIS | 4 0.04 94.27 TUMOUR EMBOLISM | 1 0.01 94.28 TUMOUR HAEMORRHAGE | 1 0.01 94.29 TUMOUR INVASION | 1 0.01 94.30 TUMOUR LYSIS SYNDROME | 4 0.04 94.34 TUMOUR MARKER INCREASED | 1 0.01 94.35 TYPE 2 DIABETES MELLITUS | 3 0.03 94.38 TYPE III IMMUNE COMPLEX MEDIATED REAC.. | 1 0.01 94.39 ULCER | 2 0.02 94.41 UMBILICAL HERNIA | 1 0.01 94.42 UNDERDOSE | 2 0.02 94.44 UNEVALUABLE EVENT | 15 0.15 94.59 UNINTENDED PREGNANCY | 1 0.01 94.60 UNRESPONSIVE TO STIMULI | 5 0.05 94.65 UNWANTED AWARENESS DURING ANAESTHESIA | 1 0.01 94.66 UPPER GASTROINTESTINAL HAEMORRHAGE | 1 0.01 94.67 UPPER LIMB FRACTURE | 6 0.06 94.73 UPPER RESPIRATORY TRACT INFECTION | 2 0.02 94.75 UPPER RESPIRATORY TRACT INFLAMMATION | 2 0.02 94.77 URETHRAL OBSTRUCTION | 2 0.02 94.79 URETHRAL OPERATION | 1 0.01 94.80 URINARY INCONTINENCE | 8 0.08 94.88 URINARY RETENTION | 6 0.06 94.94 URINARY SEDIMENT ABNORMAL | 1 0.01 94.95 URINARY TRACT DISORDER | 2 0.02 94.97 URINARY TRACT INFECTION | 21 0.21 95.18 URINARY TRACT INFECTION PSEUDOMONAL | 1 0.01 95.19 URINE ABNORMALITY | 1 0.01 95.20 URINE ANALYSIS ABNORMAL | 1 0.01 95.21 URINE LEUKOCYTE ESTERASE POSITIVE | 1 0.01 95.22 URINE OUTPUT DECREASED | 4 0.04 95.26 UROSEPSIS | 2 0.02 95.28 URTICARIA | 44 0.44 95.72 UTERINE DISORDER | 1 0.01 95.73 UTERINE ENLARGEMENT | 1 0.01 95.74 UTERINE HAEMORRHAGE | 5 0.05 95.79 UTERINE LEIOMYOMA | 8 0.08 95.87 UTERINE OPERATION | 1 0.01 95.88 UTERINE RUPTURE | 20 0.20 96.08 UTERINE SPASM | 1 0.01 96.09 UVEITIS | 6 0.06 96.15 VAGINAL HAEMORRHAGE | 11 0.11 96.26 VAGINAL INFECTION | 1 0.01 96.27 VAGINAL NEOPLASM | 1 0.01 96.28 VANISHING BILE DUCT SYNDROME | 1 0.01 96.29 VARICES OESOPHAGEAL | 1 0.01 96.30 VARICOSE VEIN | 1 0.01 96.31 VASCULAR INJURY | 2 0.02 96.33 VASCULAR RUPTURE | 1 0.01 96.34 VASCULITIS | 5 0.05 96.39 VASCULITIS CEREBRAL | 1 0.01 96.40 VASOSPASM | 1 0.01 96.41 VEIN DISORDER | 1 0.01 96.42 VENA CAVA THROMBOSIS | 1 0.01 96.43 VENOOCCLUSIVE LIVER DISEASE | 1 0.01 96.44 VENOUS INSUFFICIENCY | 1 0.01 96.45 VENOUS OCCLUSION | 1 0.01 96.46 VENOUS PRESSURE JUGULAR DECREASED | 1 0.01 96.47 VENTRICULAR DYSFUNCTION | 1 0.01 96.48 VENTRICULAR EXTRASYSTOLES | 3 0.03 96.51 VENTRICULAR FIBRILLATION | 5 0.05 96.56 VENTRICULAR HYPOKINESIA | 1 0.01 96.57 VENTRICULAR SEPTAL DEFECT | 1 0.01 96.58 VENTRICULAR TACHYCARDIA | 2 0.02 96.60 VERTIGO | 8 0.08 96.68 VERTIGO POSITIONAL | 1 0.01 96.69 VICTIM OF CRIME | 1 0.01 96.70 VICTIM OF HOMICIDE | 1 0.01 96.71 VIRAL INFECTION | 5 0.05 96.76 VISION BLURRED | 21 0.21 96.97 VISUAL ACUITY REDUCED | 14 0.14 97.11 VISUAL FIELD DEFECT | 1 0.01 97.12 VISUAL IMPAIRMENT | 10 0.10 97.22 VITAMIN B12 DECREASED | 1 0.01 97.23 VITAMIN B12 DEFICIENCY | 2 0.02 97.25 VITAMIN B6 DECREASED | 1 0.01 97.26 VITAMIN D DECREASED | 2 0.02 97.28 VITAMIN D DEFICIENCY | 1 0.01 97.29 VOCAL CORD PARALYSIS | 1 0.01 97.30 VOMITING | 87 0.87 98.17 VOMITING PROJECTILE | 1 0.01 98.18 VULVOVAGINAL DRYNESS | 1 0.01 98.19 WALDENSTROM'S MACROGLOBULINAEMIA | 1 0.01 98.20 WALKING AID USER | 2 0.02 98.22 WALKING DISABILITY | 1 0.01 98.23 WEGENER'S GRANULOMATOSIS | 1 0.01 98.24 WEIGHT DECREASED | 40 0.40 98.64 WEIGHT FLUCTUATION | 4 0.04 98.68 WEIGHT GAIN POOR | 1 0.01 98.69 WEIGHT INCREASED | 24 0.24 98.93 WHEELCHAIR USER | 3 0.03 98.96 WHEEZING | 10 0.10 99.06 WHITE BLOOD CELL COUNT ABNORMAL | 2 0.02 99.08 WHITE BLOOD CELL COUNT DECREASED | 23 0.23 99.31 WHITE BLOOD CELL COUNT INCREASED | 12 0.12 99.43 WHITE BLOOD CELL DISORDER | 2 0.02 99.45 WITHDRAWAL SYNDROME | 8 0.08 99.53 WOUND | 2 0.02 99.55 WOUND COMPLICATION | 2 0.02 99.57 WOUND DRAINAGE | 1 0.01 99.58 WOUND HAEMORRHAGE | 1 0.01 99.59 WOUND INFECTION | 1 0.01 99.60 WOUND INFECTION STAPHYLOCOCCAL | 2 0.02 99.62 WOUND SECRETION | 1 0.01 99.63 WOUND TREATMENT | 1 0.01 99.64 WRIST FRACTURE | 2 0.02 99.66 WRONG DRUG ADMINISTERED | 3 0.03 99.69 WRONG TECHNIQUE IN DRUG USAGE PROCESS | 26 0.26 99.95 X-RAY ABNORMAL | 1 0.01 99.96 XEROPHTHALMIA | 1 0.01 99.97 YAWNING | 1 0.01 99.98 YELLOW SKIN | 2 0.02 100.00 ----------------------------------------+----------------------------------- Total | 10,000 100.00 by Jean Roth , jroth@nber.org , 18 Dec 2015